This is a Validated Antibody Database (VAD) review about mouse Ccnd1, based on 464 published articles (read how Labome selects the articles), using Ccnd1 antibody in all methods. It is aimed to help Labome visitors find the most suited Ccnd1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ccnd1 synonym: AI327039; CycD1; Cyl-1; PRAD1; bcl-1; cD1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (DCS-6)
  • immunocytochemistry knockout validation; mouse; loading ...; fig 4b
  • immunohistochemistry knockout validation; mouse; loading ...; fig 1f
  • western blot knockout validation; mouse; loading ...; fig 2b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in immunocytochemistry knockout validation on mouse samples (fig 4b), in immunohistochemistry knockout validation on mouse samples (fig 1f) and in western blot knockout validation on mouse samples (fig 2b). Cell Rep (2020) ncbi
Abcam
domestic rabbit monoclonal (EPR2241)
  • western blot knockout validation; mouse; loading ...; fig 7m
  • western blot; rat; loading ...; fig 5a
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot knockout validation on mouse samples (fig 7m) and in western blot on rat samples (fig 5a). J Cell Biol (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (92G2)
  • western blot knockout validation; mouse; loading ...; fig 2a
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot knockout validation on mouse samples (fig 2a) and in western blot on human samples (fig 2c). Nature (2018) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (92G2)
  • western blot knockout validation; mouse; loading ...; fig 3b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot knockout validation on mouse samples (fig 3b). Mol Pharmacol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-12)
  • western blot; mouse; 1:1000; loading ...
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on mouse samples at 1:1000. Nat Commun (2022) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:200; loading ...; fig 1f
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples at 1:200 (fig 1f). Int J Mol Sci (2022) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:2000; loading ...; fig 3e
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples at 1:2000 (fig 3e). iScience (2022) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples (fig 4a). Pathol Oncol Res (2022) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on human samples (fig 7c). Cell Rep (2021) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; 1:500; loading ...; fig 5c
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on mouse samples at 1:500 (fig 5c). Int J Mol Sci (2021) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500; loading ...
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on human samples at 1:500. Cancers (Basel) (2021) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples at 1:1000 (fig 5g). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; 1:300; fig 5a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on mouse samples at 1:300 (fig 5a). J Cell Mol Med (2021) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples at 1:1000 (fig 5d). Mol Med Rep (2021) ncbi
mouse monoclonal (HD11)
  • western blot; human; loading ...; fig 6g
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on human samples (fig 6g). BMC Cancer (2021) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:1000; loading ...; fig 2e
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, SC-8396) was used in western blot on human samples at 1:1000 (fig 2e). elife (2020) ncbi
mouse monoclonal (DCS-6)
  • immunocytochemistry knockout validation; mouse; loading ...; fig 4b
  • immunohistochemistry knockout validation; mouse; loading ...; fig 1f
  • western blot knockout validation; mouse; loading ...; fig 2b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in immunocytochemistry knockout validation on mouse samples (fig 4b), in immunohistochemistry knockout validation on mouse samples (fig 1f) and in western blot knockout validation on mouse samples (fig 2b). Cell Rep (2020) ncbi
mouse monoclonal (A-12)
  • flow cytometry; human; loading ...; fig 6b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, A-12) was used in flow cytometry on human samples (fig 6b). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples at 1:1000 (fig 2c). J Cancer (2020) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; 1:200; loading ...; fig 7b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on mouse samples at 1:200 (fig 7b). Front Oncol (2020) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; loading ...; fig 2i
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples (fig 2i). Mol Cancer (2020) ncbi
mouse monoclonal (72-13G)
  • western blot; human; 1:1000; loading ...; fig 4b
Santa Cruz Biotechnology Ccnd1 antibody (Santa, sc-450) was used in western blot on human samples at 1:1000 (fig 4b). BMC Gastroenterol (2019) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; loading ...; fig 6d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotech, SC20044) was used in western blot on human samples at 1:1000 (fig 6d). Science (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 5g
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples (fig 5g). J Exp Clin Cancer Res (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 5d
Santa Cruz Biotechnology Ccnd1 antibody (Santa, sc-8396) was used in western blot on human samples (fig 5d). Cells (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology Ccnd1 antibody (Santa, sc-8396) was used in western blot on human samples at 1:500 (fig 4a). Biosci Rep (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500; loading ...; fig 6d
Santa Cruz Biotechnology Ccnd1 antibody (Santa, sc-8396) was used in western blot on human samples at 1:500 (fig 6d). Aging (Albany NY) (2019) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; loading ...; fig 5d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, A-12) was used in western blot on mouse samples (fig 5d). Sci Rep (2019) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; loading ...; fig 3d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples (fig 3d). Front Immunol (2019) ncbi
mouse monoclonal (72-13G)
  • western blot; human; 1:1000; loading ...; fig 2f
Santa Cruz Biotechnology Ccnd1 antibody (Santa cruz, SC-450) was used in western blot on human samples at 1:1000 (fig 2f). Nat Commun (2019) ncbi
mouse monoclonal (6D328)
  • western blot; human; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-70899) was used in western blot on human samples at 1:1000 (fig 7a). Biomed Res Int (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Ccnd1 antibody (Santa, sc-8396) was used in western blot on human samples (fig 4a). J Pathol (2019) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, A-12) was used in western blot on human samples (fig 2d). PLoS Pathog (2018) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500; loading ...; fig 2d
In order to identify XBP1-u as a regulator of the MDM2/p53 function, Santa Cruz Biotechnology Ccnd1 antibody (SantaCruz, sc-8396) was used in western blot on human samples at 1:500 (fig 2d). Sci Adv (2017) ncbi
mouse monoclonal (A-12)
  • western blot; human; fig 2b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples (fig 2b). Oncol Lett (2017) ncbi
mouse monoclonal (72-13G)
  • immunocytochemistry; mouse; loading ...; fig 2l
  • western blot; mouse; loading ...; fig 2m
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, 72-13G) was used in immunocytochemistry on mouse samples (fig 2l) and in western blot on mouse samples (fig 2m). J Biol Chem (2017) ncbi
mouse monoclonal (DCS-6)
  • immunoprecipitation; human; loading ...; fig 4b
  • immunocytochemistry; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Ccnd1 antibody (SantaCruz, sc-20044) was used in immunoprecipitation on human samples (fig 4b), in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 4b). Oncogene (2017) ncbi
mouse monoclonal (72-13G)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-450) was used in western blot on human samples (fig 3b). Life Sci (2017) ncbi
mouse monoclonal (A-12)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4f
Santa Cruz Biotechnology Ccnd1 antibody (Santa-Cruz, 8396) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4f). Biol Open (2017) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; loading ...; fig 2b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples (fig 2b). PLoS ONE (2017) ncbi
mouse monoclonal (72-13G)
  • western blot; human; loading ...; fig 6c
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-450) was used in western blot on human samples (fig 6c). Peerj (2017) ncbi
mouse monoclonal (6D328)
  • western blot; human; 1:1000; loading ...; fig 4a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-70899) was used in western blot on human samples at 1:1000 (fig 4a). Exp Ther Med (2016) ncbi
mouse monoclonal (72-13G)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; tbl 2
In order to examine the effects of retinal progenitor cell proliferation on the spatiotemporal differentiation and synaptic development of rods and bipolar cells in early postnatal gestational lead exposure retinas, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, SC-450) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (tbl 2). Mol Vis (2016) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 2b
In order to investigate how 6-C-(E-phenylethenyl)naringenin inhibits cancer cell growth, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples (fig 2b). Eur J Cancer (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; 1:1000; fig s1
  • western blot; human; 1:1000; fig 1
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples at 1:1000 (fig s1) and in western blot on human samples at 1:1000 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (72-13G)
  • western blot; human; 1:100; fig 6
In order to determine the role of miR-506 in osteosarcoma pathogenesis, Santa Cruz Biotechnology Ccnd1 antibody (santa Cruz, sc-450) was used in western blot on human samples at 1:100 (fig 6). Oncol Lett (2016) ncbi
mouse monoclonal (A-12)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, A-12) was used in western blot on human samples (fig 2b). Oncol Rep (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:3000; loading ...; fig 5a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples at 1:3000 (fig 5a). Mol Med Rep (2016) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:1000; loading ...; fig 1g
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples at 1:1000 (fig 1g). Mol Med Rep (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 4
Santa Cruz Biotechnology Ccnd1 antibody (santa Cruz, sc-20044) was used in western blot on human samples (fig 4). Cancer Gene Ther (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; loading ...; fig s1
Santa Cruz Biotechnology Ccnd1 antibody (SantaCruz, sc20044) was used in western blot on human samples at 1:1000 (fig s1). Oncotarget (2016) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; 1:400; loading ...; fig 1b
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on mouse samples at 1:400 (fig 1b). J Orthop Res (2017) ncbi
mouse monoclonal (72-13G)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology Ccnd1 antibody (santa Cruz, sc-450) was used in western blot on mouse samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig s1
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples at 1:1000 (fig s1). EMBO Mol Med (2016) ncbi
mouse monoclonal (72-13G)
  • immunocytochemistry; mouse; 1:200; fig 5
In order to determine regulation of metastasis and cell invasion through the phosphorylation of paxillin due to cytoplasmic cyclin D1, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in immunocytochemistry on mouse samples at 1:200 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; tbl 1
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples (tbl 1). Sci Rep (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 1
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples (fig 1). Onco Targets Ther (2016) ncbi
mouse monoclonal (DCS-6)
  • immunocytochemistry; human; 1:100; fig 5
In order to study APC/C(Cdh1) function, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in immunocytochemistry on human samples at 1:100 (fig 5). Nucleic Acids Res (2016) ncbi
mouse monoclonal (A-12)
  • western blot; human; fig 4
  • western blot; mouse; fig 8
In order to learn about inhibition of stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis via cucurbitacin B, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, SC-8396) was used in western blot on human samples (fig 4) and in western blot on mouse samples (fig 8). Sci Rep (2016) ncbi
mouse monoclonal (72-13G)
  • immunohistochemistry; mouse; 1:200; fig 3
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-450) was used in immunohistochemistry on mouse samples at 1:200 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (DCS-6)
  • immunohistochemistry; rat; 1:50; loading ...; fig 5c
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in immunohistochemistry on rat samples at 1:50 (fig 5c). Mol Med Rep (2016) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 1
In order to investigate proteolytic processing of p27, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
mouse monoclonal (A-12)
  • western blot; human; fig 4
In order to investigate the role of MycN in normal human neural crest development, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (6D328)
  • western blot; human; 1:1000; fig 6
In order to analyze a Kawasaki disease model and how TNF alpha induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-70899) was used in western blot on human samples at 1:1000 (fig 6). Int J Biochem Cell Biol (2016) ncbi
mouse monoclonal (72-13G)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 3
In order to assess the Wnt-dependent regulation and midbrain-to-forebrain identity switch by loss of Ezh2, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3). BMC Biol (2015) ncbi
mouse monoclonal (HD11)
  • western blot; mouse; fig 2
Santa Cruz Biotechnology Ccnd1 antibody (santa Cruz, sc-246) was used in western blot on mouse samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (72-13G)
  • western blot; mouse; fig s3
In order to reveal Cyclin D1 dynamics in adult mice by hyper sensitive protein detection by tandem-HTRF, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in western blot on mouse samples (fig s3). Sci Rep (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig s3
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples at 1:1000 (fig s3). PLoS ONE (2015) ncbi
mouse monoclonal (A-12)
  • western blot; human; fig 8e
Santa Cruz Biotechnology Ccnd1 antibody (santa cruz, sc-8396) was used in western blot on human samples (fig 8e). J Biol Chem (2015) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:5000; fig 1
Santa Cruz Biotechnology Ccnd1 antibody (santa Cruz, sc-8396) was used in western blot on human samples at 1:5000 (fig 1). J Cancer (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 7
In order to study the role of transmembrane protein 33 in the unfolded protein response, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples at 1:1000 (fig 7). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (HD11)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Laboratories, SC246) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (DCS-6)
  • flow cytometry; human; fig 6
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in flow cytometry on human samples (fig 6). Melanoma Res (2015) ncbi
rat monoclonal (34B1-3)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-452) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (HD11)
  • western blot; human; fig 1
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on human samples (fig 1). J Biomed Sci (2015) ncbi
mouse monoclonal (HD11)
  • chromatin immunoprecipitation; mouse; fig 2
  • western blot; mouse; fig 2
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in chromatin immunoprecipitation on mouse samples (fig 2) and in western blot on mouse samples (fig 2). Nucleic Acids Res (2015) ncbi
mouse monoclonal (72-13G)
  • immunoprecipitation; human; 1:500; fig 7
In order to elucidate how VRK1 regulates Cajal bodies stability and dynamics, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-450) was used in immunoprecipitation on human samples at 1:500 (fig 7). Sci Rep (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 1
In order to analyze the anti-cancer effect of fucoidan on human colon cancer cells, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples at 1:1000 (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; fig 4
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (HD11)
  • western blot; mouse; 1:500; fig 4a
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on mouse samples at 1:500 (fig 4a). PLoS ONE (2015) ncbi
mouse monoclonal (HD11)
  • western blot; human; 1:200
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotech, SC-246) was used in western blot on human samples at 1:200. Front Cell Dev Biol (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; 1:800; loading ...; fig 5
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples at 1:800 (fig 5). Exp Ther Med (2015) ncbi
mouse monoclonal (HD11)
  • immunocytochemistry; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-246) was used in immunocytochemistry on human samples . Int J Oncol (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1500
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotech, sc-20044) was used in western blot on human samples at 1:1500. Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 2
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples at 1:1000 (fig 2). J Cell Mol Med (2015) ncbi
mouse monoclonal (72-13G)
  • immunohistochemistry - frozen section; mouse; 1:600
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in immunohistochemistry - frozen section on mouse samples at 1:600. Dev Genes Evol (2015) ncbi
mouse monoclonal (A-12)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 1
In order to show that Lhx4 is needed for efficient pituitary progenitor cell proliferation and restriction of p21 expression, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1). Mol Endocrinol (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:300
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples at 1:300. Mol Cancer (2015) ncbi
mouse monoclonal (72-13G)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in western blot on human samples . Acta Biochim Biophys Sin (Shanghai) (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 3
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples (fig 3). Cell Cycle (2015) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500; fig 5
In order to characterize multidrug-resistant cancer cells and attenuation of proteasome inhibitor-mediated apoptosis by ABCB1 expression and Wnt pathway activation, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples at 1:500 (fig 5). Cancer Biol Ther (2015) ncbi
mouse monoclonal (HD11)
  • western blot; rat; fig 4
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on rat samples (fig 4) and in western blot on mouse samples at 1:1000. J Cell Mol Med (2015) ncbi
mouse monoclonal (72-13G)
  • immunocytochemistry; mouse; 1:500; fig 3
  • western blot; mouse; 1:500; fig 6
In order to study the contribution of ZO-1, -2, and -3 on collecting duct cell proliferation, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-450) was used in immunocytochemistry on mouse samples at 1:500 (fig 3) and in western blot on mouse samples at 1:500 (fig 6). Cell Cycle (2014) ncbi
mouse monoclonal (DCS-6)
  • immunohistochemistry - paraffin section; human; 1:100
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2014) ncbi
mouse monoclonal (A-12)
  • western blot; human
In order to study the role of Wnt5A signaling in cancer drug resistance, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (A-12)
  • western blot; human; 1:500
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on human samples at 1:500. Oncotarget (2014) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; loading ...; fig 1d
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on mouse samples (fig 1d). Oncotarget (2014) ncbi
mouse monoclonal (A-12)
  • western blot; mouse; 1:400; fig 2
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on mouse samples at 1:400 (fig 2). Cell Physiol Biochem (2014) ncbi
mouse monoclonal (72-13G)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotech, sc-450) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:200
In order to investigate the role of Zbed3 in malignant phenotype of lung cancer, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples at 1:200. Mol Carcinog (2015) ncbi
mouse monoclonal (HD11)
  • western blot; mouse
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on mouse samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 4
In order to determine that decreased lipid synthesis in breast cancer cells and its association with acetylated-defective mutant of Ppary, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, DCS-6) was used in western blot on human samples (fig 4). Oncotarget (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples . BMC Cancer (2014) ncbi
mouse monoclonal (72-13G)
  • western blot; mouse
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in western blot on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (DCS-6)
  • immunohistochemistry; mouse
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, DCS-6) was used in immunohistochemistry on mouse samples . Head Neck (2015) ncbi
mouse monoclonal (A-12)
  • western blot; human; fig 6
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-8396) was used in western blot on human samples (fig 6). J Pathol (2014) ncbi
mouse monoclonal (A-12)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples . Br J Pharmacol (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:500
In order to investigate the signalling pathways involved in the development of invasive trophoblasts, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples at 1:500. Mol Hum Reprod (2014) ncbi
mouse monoclonal (72-13G)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, 72-13G) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples . Cancer Res (2014) ncbi
mouse monoclonal (A-12)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in western blot on human samples . Cancer Lett (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on mouse samples . J Hepatol (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-20044) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (72-13G)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-450) was used in western blot on human samples . Neuro Oncol (2013) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz Biotechnology, sc-20044) was used in western blot on human samples . Am J Physiol Endocrinol Metab (2011) ncbi
mouse monoclonal (HD11)
  • western blot; human; fig 3
Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-246) was used in western blot on human samples (fig 3). Clin Cancer Res (2010) ncbi
mouse monoclonal (A-12)
  • immunohistochemistry - paraffin section; mouse; 1:50
In order to test if Brca1 loss in mammary epithelium alters the estrogenic growth response and if exposure to increased estrogen or ERalpha correlates with Brca1 deficiency, Santa Cruz Biotechnology Ccnd1 antibody (Santa Cruz, sc-8396) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. Oncogene (2008) ncbi
Abcam
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4b
  • western blot; mouse; 1:1000; loading ...; fig 6h
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4b) and in western blot on mouse samples at 1:1000 (fig 6h). Cell Rep Med (2022) ncbi
domestic rabbit monoclonal
  • immunocytochemistry; human; loading ...; fig 4a
Abcam Ccnd1 antibody (Abcam, ab156448) was used in immunocytochemistry on human samples (fig 4a). iScience (2022) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 7d
  • western blot; mouse; 1:500; fig 7c
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 7d) and in western blot on mouse samples at 1:500 (fig 7c). Int J Biol Sci (2022) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry; human; loading ...; fig 6c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry on human samples (fig 6c). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry - paraffin section; mouse; fig 7c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry - paraffin section on mouse samples (fig 7c). Cell Mol Life Sci (2022) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry; human; loading ...; fig 4e
  • western blot; human; loading ...; fig 4c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry on human samples (fig 4e) and in western blot on human samples (fig 4c). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; mouse; 1:50; loading ...; fig 5f
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on mouse samples at 1:50 (fig 5f). J Cell Mol Med (2021) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:200; loading ...; fig 4c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:200 (fig 4c). Int J Oncol (2021) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; loading ...; fig 1j
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 1j). iScience (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot knockout validation; mouse; loading ...; fig 7m
  • western blot; rat; loading ...; fig 5a
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot knockout validation on mouse samples (fig 7m) and in western blot on rat samples (fig 5a). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 7b
Abcam Ccnd1 antibody (abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 7b). Oncoimmunology (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig s6b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig s6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; mouse; loading ...; fig 5c
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on mouse samples (fig 5c). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:1000; loading ...; fig 3h
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:1000 (fig 3h). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry; mouse; 1:400; loading ...
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry on mouse samples at 1:400. Oncol Rep (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunoprecipitation; mouse; loading ...; fig 6a
  • western blot; mouse; 1:500; loading ...; fig 1f
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunoprecipitation on mouse samples (fig 6a) and in western blot on mouse samples at 1:500 (fig 1f). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6c
Abcam Ccnd1 antibody (Abcam, 134175) was used in immunohistochemistry on mouse samples at 1:100 (fig 6c). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:1000 (fig 4b). Nucleic Acids Res (2021) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:200; loading ...; fig 2b
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:200 (fig 2b). Oncol Lett (2020) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:250; loading ...; fig 3e
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:250 (fig 3e). Cancer Res Treat (2021) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:10,000; loading ...; fig 6a
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:10,000 (fig 6a). Int J Mol Med (2020) ncbi
domestic rabbit monoclonal (EP272Y)
  • western blot; human; 1:1000; loading ...; fig s2d
Abcam Ccnd1 antibody (Abcam, ab40754) was used in western blot on human samples at 1:1000 (fig s2d). BMC Cancer (2020) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; loading ...; fig 2c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 2c). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig 1e
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 1e). Thorac Cancer (2020) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 1m
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry on mouse samples at 1:300 (fig 1m). Development (2020) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:100; loading ...; fig 6c, 6d
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:100 (fig 6c, 6d). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig 4h
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 4h). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:150; loading ...; fig 6b, 6d
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:150 (fig 6b, 6d). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; loading ...; fig 2j
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 2j). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EP272Y)
  • western blot; human; 1:1000; loading ...; fig 3d
Abcam Ccnd1 antibody (Abcam, ab40754) was used in western blot on human samples at 1:1000 (fig 3d). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; loading ...; fig 4a
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 4a). BMC Cancer (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:30,000; loading ...; fig 4b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:30,000 (fig 4b). Biol Res (2019) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:1000; loading ...; fig 6a
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:1000 (fig 6a). J Ovarian Res (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:1000; loading ...; fig 3
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:1000 (fig 3). Hypoxia (Auckl) (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c). Cell Rep (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:10,000; loading ...; fig 5a, 5h
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:10,000 (fig 5a, 5h). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig 6a
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 6a). elife (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; rat; loading ...; fig 2d
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on rat samples (fig 2d). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; rat; loading ...; fig 1b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on rat samples (fig 1b). Braz J Med Biol Res (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:2000; loading ...; fig 5a
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:2000 (fig 5a). J Cell Physiol (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:2000; loading ...; fig 6g
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:2000 (fig 6g). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig 3g
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 3g). Cancer Res (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:10,000; loading ...; fig 6b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:10,000 (fig 6b). Cancer Sci (2019) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s11e
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry on mouse samples at 1:100 (fig s11e). Science (2018) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 8
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 8). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3e
Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3e). J Cell Biol (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; mouse; fig 4b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on mouse samples (fig 4b). Basic Res Cardiol (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; mouse; loading ...; fig 2d
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on mouse samples (fig 2d). Genes Dev (2017) ncbi
domestic rabbit monoclonal (SP4)
Abcam Ccnd1 antibody (Abcam, ab16663) was used . Oncogene (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; loading ...; fig 7a
  • western blot; mouse; loading ...; fig 7e
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 7a) and in western blot on mouse samples (fig 7e). Oncotarget (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:1000; loading ...; fig 3b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:1000 (fig 3b). Sci Rep (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; rat; loading ...; fig 4b
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on rat samples (fig 4b). Am J Transl Res (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6a
In order to discuss how c-jun regulates astrocyte elevated gene-1 in gliomas, Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6a). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (EP272Y)
  • immunocytochemistry; human; 1:100; loading ...; fig 3d
In order to find that TrpC5 regulates differentiation in colorectal cancer, Abcam Ccnd1 antibody (Abcam, ab40754) was used in immunocytochemistry on human samples at 1:100 (fig 3d). Clin Sci (Lond) (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; fig 7g
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples (fig 7g). Sci Rep (2016) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:200; loading ...; fig 4e
Abcam Ccnd1 antibody (Abcam, Ab16663) was used in western blot on human samples at 1:200 (fig 4e). Oncogene (2017) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:250; fig 4
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:250 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; mouse; 1:2000; fig 2
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on mouse samples at 1:2000 (fig 2). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam Ccnd1 antibody (Epitomics, 2261-1) was used in western blot on human samples at 1:1000 (fig 4b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:10,000; fig 6
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:10,000 (fig 6). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (EP272Y)
  • western blot; human; loading ...; fig 6e
Abcam Ccnd1 antibody (Abcam, ab40754) was used in western blot on human samples (fig 6e). Nat Genet (2016) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:200; loading ...; fig 3a
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:200 (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; fig 1
Abcam Ccnd1 antibody (Epitomics, 2261-1) was used in western blot on human samples (fig 1). FEBS Open Bio (2016) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; fig 5a
In order to test if NOL1activates transcription of cyclin D1, Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 5a). J Cell Sci (2016) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry; mouse; 1:100; fig 1
Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry on mouse samples at 1:100 (fig 1). Cell Cycle (2016) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:1000; fig 7
Abcam Ccnd1 antibody (Epitomics, 2261) was used in western blot on human samples at 1:1000 (fig 7). J Cell Mol Med (2016) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; fig 3
In order to assess the effects of curcumin on lung cancer stem-like cells, Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig 3). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; 1:1000; loading ...; fig 5b
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples at 1:1000 (fig 5b). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; human; loading ...; fig s1c
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on human samples (fig s1c). J Cell Biol (2015) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunocytochemistry; human
In order to use transgenic mice to show that CDK5 activity is crucial for cell cycle progression and medullary thyroid carcinoma proliferation, Abcam Ccnd1 antibody (Abcam, ab134175) was used in immunocytochemistry on human samples . Oncotarget (2015) ncbi
domestic rabbit monoclonal (SP4)
  • western blot; mouse; 1:1000; fig s2
Abcam Ccnd1 antibody (Abcam, ab16663) was used in western blot on mouse samples at 1:1000 (fig s2). Nat Commun (2015) ncbi
domestic rabbit monoclonal (EP272Y)
  • immunocytochemistry; human; 1:100
Abcam Ccnd1 antibody (Abcam, ab40754) was used in immunocytochemistry on human samples at 1:100. Biochem Biophys Res Commun (2015) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; 1:10,000; fig 5
Abcam Ccnd1 antibody (Abcam, ab134175) was used in western blot on human samples at 1:10,000 (fig 5). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry - frozen section; mouse; 1:400; fig 3f
In order to explore the regulatory functions of the BMP and Wnt pathways in early tooth development, Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry - frozen section on mouse samples at 1:400 (fig 3f). Development (2015) ncbi
domestic rabbit monoclonal (EP272Y)
  • western blot; human; 1:200; fig 3f
Abcam Ccnd1 antibody (Abcam, ab40754) was used in western blot on human samples at 1:200 (fig 3f). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - frozen section; Xenopus laevis; 1:1000
  • western blot; Xenopus laevis
Abcam Ccnd1 antibody (Abcam, EPR2241) was used in immunohistochemistry - frozen section on Xenopus laevis samples at 1:1000 and in western blot on Xenopus laevis samples . PLoS Pathog (2014) ncbi
domestic rabbit monoclonal (SP4)
  • immunohistochemistry - free floating section; mouse; 1:250
In order to investigate the role of microglial derived tumor necrosis factor alpha in neuronal cell cycle progression, Abcam Ccnd1 antibody (Abcam, ab16663) was used in immunohistochemistry - free floating section on mouse samples at 1:250. Neurobiol Dis (2014) ncbi
domestic rabbit monoclonal (EPR2241)
  • western blot; human; fig 4
Abcam Ccnd1 antibody (Epitomics, 2261-1) was used in western blot on human samples (fig 4). Mol Cancer Ther (2013) ncbi
domestic rabbit monoclonal (EPR2241)
  • immunohistochemistry - paraffin section; human
Abcam Ccnd1 antibody (Epitomics, 2261-1) was used in immunohistochemistry - paraffin section on human samples . Am J Pathol (2012) ncbi
Invitrogen
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 2c
Invitrogen Ccnd1 antibody (NeoMarkers (Thermo Scientific), RM-9104) was used in immunohistochemistry on mouse samples at 1:400 (fig 2c). Development (2021) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:100; loading ...; fig ev2d
Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104-S0) was used in immunohistochemistry on mouse samples at 1:100 (fig ev2d). EMBO Mol Med (2020) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s17b
Invitrogen Ccnd1 antibody (Thermo Scientific, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s17b). Nat Med (2018) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3d
In order to examine the role of p107 and p130 proteins in lung tumorigenesis, Invitrogen Ccnd1 antibody (Thermo Scientific, SP4) was used in immunohistochemistry - paraffin section on mouse samples (fig 3d). Oncotarget (2017) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4
In order to analyze high-risk HPV incidence, prognostic biomarkers, and outcome in HIV-positive and -negative patients with head and neck squamous cell cancer, Invitrogen Ccnd1 antibody (Thermo Scientific, SP4) was used in immunohistochemistry - paraffin section on human samples (fig 4). Mol Cancer Res (2017) ncbi
domestic rabbit recombinant (SP4)
  • western blot; mouse; 1:250; loading ...; fig 9a
In order to report the effects of valproic acid exposure in utero, Invitrogen Ccnd1 antibody (ThermoFisher Scientific, RM-9104) was used in western blot on mouse samples at 1:250 (fig 9a). J Neurosci (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to characterize three immunocompetent patients with primary cardiac diffuse large B-cell lymphoma, Invitrogen Ccnd1 antibody (Thermo Fisher, SP4) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Ann Diagn Pathol (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 9
In order to determine the roles of LGR4 and LGR5 in hair cell differentiation in the embryonic cochlea, Invitrogen Ccnd1 antibody (Thermo Fisher Scientific, MA5-14512) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 9). Front Cell Neurosci (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; rat; 1:250; fig 3
In order to study alterations in the cell cycle using an animal model of NDE1-associated microcephaly, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104) was used in immunohistochemistry on rat samples at 1:250 (fig 3). Nat Commun (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
In order to study the effect of beta-catenin and cyclin D1 on overall survival in patients with early-stage NSCLC, Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples (fig 1a). J Thorac Oncol (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:20; fig 2e
In order to investigate cyclin D1 in T-cell lymphomas, Invitrogen Ccnd1 antibody (ThermoFisher Scientific, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 2e). Mod Pathol (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1g
In order to present an unusual case of mantle cell lymphoma, Invitrogen Ccnd1 antibody (ThermoFisher, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1g). Virchows Arch (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 4a
In order to investigate the contribution of Huwe1 in proliferating stem cells of the adult mouse hippocampus to the return to quiescence, Invitrogen Ccnd1 antibody (ThermoScientific, RM-9104) was used in immunohistochemistry on mouse samples at 1:400 (fig 4a). Science (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
In order to confirm the predilection for papillary renal cell carcinomas in patients with kidney allografts, Invitrogen Ccnd1 antibody (Thermo Fisher, SP4) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Hum Pathol (2016) ncbi
domestic rabbit recombinant (SP4)
  • western blot; human; fig 4
In order to analyze MicroRNA-193a arm selection preference that varies in breast cancer, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104-S) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunocytochemistry; human; 1:10; loading ...; fig 5
In order to discuss mechanisms of mTOR-I-associated pulmonary toxicity, Invitrogen Ccnd1 antibody (Thermo Scientific, SP4) was used in immunocytochemistry on human samples at 1:10 (fig 5). J Nephrol (2016) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to measure galectin-3, cytokeratin-19, HBME-1, fibronectin, and cyclin D1 expression in cells of benign, malignant, and borderline tumors, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Bull Exp Biol Med (2016) ncbi
domestic rabbit recombinant (SP4)
  • western blot; mouse; 1:50; fig 2
In order to characterize how mitochondrial Ca(21) uptake through MICU1 regulation dictates tissue regeneration and survival, Invitrogen Ccnd1 antibody (Thermo Scientific, MA1-39546) was used in western blot on mouse samples at 1:50 (fig 2). Nat Commun (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; 1:25; fig 1
In order to perform an automated analysis of proliferation involving apoptotic markers in papillary thyroid cancinoma, Invitrogen Ccnd1 antibody (Thermo Scientific, RM9104-R7) was used in immunohistochemistry on human samples at 1:25 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunocytochemistry; human; fig 2b
In order to assess survivin and cycline D1 expression in mucinous ovarian neoplasms and correlate their expression with clinicopathological variables in mucinous ovarian cancer, Invitrogen Ccnd1 antibody (Thermo Scientific, SP4) was used in immunocytochemistry on human samples (fig 2b). J Mol Histol (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; rat; fig 1
In order to categorize sequential and independent roles for KIF1A kinesin, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104-S0) was used in immunohistochemistry on rat samples (fig 1). Nat Neurosci (2016) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:500; fig 3e
In order to study the cytotoxic effects of PTC-209 in biliary tract cancer cells, Invitrogen Ccnd1 antibody (Thermo Fisher, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3e). Oncotarget (2016) ncbi
domestic rabbit recombinant (SP4)
  • western blot; human; fig 4
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Invitrogen Ccnd1 antibody (Thermoscientific, RM-9104-S) was used in western blot on human samples (fig 4). Mol Cancer (2015) ncbi
domestic rabbit recombinant (SP4)
  • western blot; human; 1:1000; loading ...; fig 4C
In order to determine the role of INSM1 in lung cancer, Invitrogen Ccnd1 antibody (Neomarkers, PM-9104) was used in western blot on human samples at 1:1000 (fig 4C). Am J Pathol (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 9
  • western blot; mouse; fig 3
In order to elucidate driven pathogenesis of BCCs in Gorlin syndrome by Shh and p50/Bcl3 signaling crosstalk, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104-s1) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 9) and in western blot on mouse samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:25
In order to analyze a phase II study in elderly patients with esophageal squamous cell carcinoma with concurrent radiotherapy with gefitinib, Invitrogen Ccnd1 antibody (Neomarker, RM-9104-S) was used in immunohistochemistry - paraffin section on human samples at 1:25. Oncotarget (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; fig s4
In order to identify mutations in desmoplastic melanoma samples, Invitrogen Ccnd1 antibody (Thermo Fisher, RM-914-S) was used in immunohistochemistry on human samples (fig s4). Nat Genet (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunocytochemistry; human; 1:200; fig 3
In order to study Pax6 expression in murine basal progenitors, Invitrogen Ccnd1 antibody (Thermo, MA1-39546) was used in immunocytochemistry on human samples at 1:200 (fig 3). PLoS Biol (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
In order to use an oral-specific chemical carcinogenesis model to study periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis that promote tumor progression, Invitrogen Ccnd1 antibody (Thermo Scientific, RM9104-S0) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Oncotarget (2015) ncbi
domestic rabbit recombinant (17H3L3)
  • western blot; human; 1:500; fig 1c
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen Ccnd1 antibody (Life Technologies, 17H3L3) was used in western blot on human samples at 1:500 (fig 1c). J Exp Med (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncotarget (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human
Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples . Mod Pathol (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:25; fig 6
In order to study a retrospective single-center analysis using ENETS TNM-classification and immunohistochemical markers for risk stratification for neuroendocrine tumors of the pancreas, Invitrogen Ccnd1 antibody (NeoMarkers, RM-9104-R7) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 6). BMC Surg (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; 1:50; fig 2
In order to test if assessing expression of both PPP2R2A and Cyclin D1 defines a subgroup of luminal breast cancer with poor survival, Invitrogen Ccnd1 antibody (Neomarkers, SP4) was used in immunohistochemistry on human samples at 1:50 (fig 2). BMC Cancer (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Epigenetics (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human
Invitrogen Ccnd1 antibody (Labvision/Neomarkers, SP4) was used in immunohistochemistry - paraffin section on human samples . Mod Pathol (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:10
In order to describe a case of marginal zone lymphoma with extensive emperipolesis, Invitrogen Ccnd1 antibody (Thermo Fisher Scientific, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:10. Cytopathology (2016) ncbi
domestic rabbit recombinant (SP4)
In order to identify the role of IFI27 in the cell proliferation of human epidermal keratinocytes, Invitrogen Ccnd1 antibody (Thermo, RM-9104) was used . Cell Prolif (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:50
In order to examine the response and resistance to endocrine therapy in mice, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104-S1) was used in immunohistochemistry on mouse samples at 1:50. Carcinogenesis (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:10
Invitrogen Ccnd1 antibody (LabVision, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:10. Int J Lab Hematol (2015) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to study the effect of thyroid hormone on hair growth and skin homeostasis, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104-R7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. PLoS ONE (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; African green monkey; 1:80
Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry on African green monkey samples at 1:80. Endocrinology (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 4
In order to determine that decreased lipid synthesis in breast cancer cells and its association with acetylated-defective mutant of Ppary, Invitrogen Ccnd1 antibody (NeoMarker, Ab3) was used in western blot on human samples (fig 4). Oncotarget (2014) ncbi
domestic rabbit recombinant (SP4)
In order to study the pathogenesis of prostate cance, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104-R7) was used . Prostate (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; fig 4
In order to elucidate selective inhibition of translation that occurs in CSC proliferation, maintenance, metastasis that occurs through 4EGI-1 that targets breast cancer stem cells, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104-S) was used in immunohistochemistry on human samples (fig 4). Oncotarget (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:50
In order to study the effect of estradiol and androgens in severely diabetic male mice, Invitrogen Ccnd1 antibody (Thermo Scientific, RM-9104-S0) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. Endocrinology (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 1e
In order to learn how active PI3K signaling is required for WNT signaling and distant metastasis in colon cancer through nuclear beta-catenin transcriptional activity, Invitrogen Ccnd1 antibody (Neomarkers, DCS-6) was used in western blot on human samples at 1:1000 (fig 1e). Oncotarget (2014) ncbi
domestic rabbit recombinant (SP4)
  • western blot; mouse
In order to study the TgCRND8 mouse model of Alzheimer's disease and how the expression of apoptosis inducing factor (AIF) is associated with cell death in the cortex but not the hippocampus, Invitrogen Ccnd1 antibody (Neomarker, RM-9104-S1) was used in western blot on mouse samples . BMC Neurosci (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:500; fig 7b
In order to determine a compartment boundary in the mouse lung demarcated by two nested developmental waves, Invitrogen Ccnd1 antibody (ThermoFisher, RM9104S0) was used in immunohistochemistry on mouse samples at 1:500 (fig 7b). Nat Commun (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:200
In order to correlate the major cell cycle stages (G1, S-G2, and G2-M) with melanoma development and progression, Invitrogen Ccnd1 antibody (Thermo Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:200. Virchows Arch (2014) ncbi
domestic rabbit recombinant (SP4)
  • western blot; human; 1:1000
In order to report on the development and characterization of a human pancreatic beta-cell line that is conditionally immortalized, Invitrogen Ccnd1 antibody (NeoMarkers, RM-9104-S1) was used in western blot on human samples at 1:1000. J Clin Invest (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100
In order to characterize a well-differentiated fetal lung adenocarcinoma from a human, Invitrogen Ccnd1 antibody (Thermo Fisher Scientific, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Chin J Cancer Res (2014) ncbi
domestic rabbit recombinant (SP4)
In order to study the role of cyclin D1 in glial progenitor cells of the adult cerebral cortex, Invitrogen Ccnd1 antibody (NeoMarkers, RM-9104) was used . Glia (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human
In order to establish a tissue quality index as an intrinsic control for measurement of different effects of preanalytical variables on FFPE tissue, Invitrogen Ccnd1 antibody (Thermo, SP4) was used in immunohistochemistry - paraffin section on human samples . Lab Invest (2014) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; fig 2a
  • western blot; mouse
  • immunohistochemistry - paraffin section; human; fig 3e
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Invitrogen Ccnd1 antibody (Thermo, SP4) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a), in western blot on mouse samples and in immunohistochemistry - paraffin section on human samples (fig 3e). PLoS ONE (2014) ncbi
domestic rabbit recombinant (SP4)
  • western blot; mouse
In order to assess how plant sterol esters alter intestinal tumorigenesis in adenomatous polyposis coli mice, Invitrogen Ccnd1 antibody (NeoMarkers, SP4) was used in western blot on mouse samples . Nutr Cancer (2014) ncbi
domestic rabbit recombinant (SP4)
  • western blot; dogs; 1:200; fig 7
  • western blot; human; 1:200; fig 7
In order to perform a comparative study of the gene expression profiles of canine and human diffuse large B-cell lymphoma with particular reference to the NFkB pathway, Invitrogen Ccnd1 antibody (Thermo Fisher, RM-9104) was used in western blot on dogs samples at 1:200 (fig 7) and in western blot on human samples at 1:200 (fig 7). PLoS ONE (2013) ncbi
domestic rabbit recombinant (SP4)
In order to evaluate the effect of NVP-BEZ235 and MEK inhibitor ADZ4266 on murine mismatch repair deficient tumors, Invitrogen Ccnd1 antibody (Thermo-Scientific, RM-9104-S1) was used . PLoS ONE (2013) ncbi
mouse monoclonal (AM29)
  • western blot; human
In order to report that loss of WRN activates the ATM-YAP-PML-p53 axis to accelerate cellular senescence, Invitrogen Ccnd1 antibody (Invitrogen, AM29) was used in western blot on human samples . Cell Death Differ (2013) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:300
In order to study the role of cyclin D1 and Cdk4 in the cerebral cortical injury-induced proliferation of Olig2-positive oligodendrocyte progenitors in a murine model, Invitrogen Ccnd1 antibody (NeoMarkers, RM-9104) was used in immunohistochemistry on mouse samples at 1:300. Glia (2013) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Laryngoscope (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig s1e
In order to study the antitumor properties and mechanistic functions of PD-0332991 in prostate cancer models, Invitrogen Ccnd1 antibody (Neomarkers, AB3) was used in western blot on human samples (fig s1e). Oncogene (2013) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse
In order to identify the effect of resveratrol on clonal expansion and terminal adipogenesis in 3T3-L1 preadipocytes, Invitrogen Ccnd1 antibody (Thermofisher, DCS-6) was used in western blot on mouse samples . J Gerontol A Biol Sci Med Sci (2013) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:25; tbl 1
In order to examine the expression of beta-catenin and related proliferation and apoptotic factors in familial adenomatous polyposis patients, Invitrogen Ccnd1 antibody (Thermo, RM-9104-S) was used in immunohistochemistry - paraffin section on human samples at 1:25 (tbl 1). Gastroenterol Res Pract (2013) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:10; tbl 2
In order to discuss how Epstein-Barr virus contributes to the development of small B-cell neoplasms, Invitrogen Ccnd1 antibody (Neomarkers, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:10 (tbl 2). PLoS ONE (2012) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; fig 2
In order to determine the role of plasminogen activator inhibitor-1 and its relationship to hypoxia and the expression of p53, Ku70/80, and cyclin D1 in cervical cancer, Invitrogen Ccnd1 antibody (Zymed, clone AM29) was used in immunohistochemistry - paraffin section on human samples (fig 2). Strahlenther Onkol (2012) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; fig 1
In order to explore the contributions of hyperglycemia and p27(kip1) suppression on islet beta cell regeneration, Invitrogen Ccnd1 antibody (Thermo Fisher Scientific, DCS-6) was used in western blot on mouse samples (fig 1). Int J Endocrinol (2012) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 1
In order to determine the expression of full-length and LMW cyclin E in bladder cancer cell lines and patient tumors, Invitrogen Ccnd1 antibody (Zymed Laboratories, clone AHF0082) was used in western blot on human samples (fig 1). Cell Cycle (2012) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 2
In order to determine the mesenchymal precursors that generate the coronal suture, Invitrogen Ccnd1 antibody (Zymed, 33-3500) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2). Development (2012) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human
In order to determine the clinicopathologic features and diagnosis of extraosseous plasmacytomas, Invitrogen Ccnd1 antibody (Thermo, SP4) was used in immunohistochemistry - paraffin section on human samples . Diagn Pathol (2011) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:50
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen Ccnd1 antibody (Lab Vision, RM-9104) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Oncol (2012) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; mouse; 1:250; fig 2
In order to study the effect of cyclin D1 in cell cycle progression of adult vestibular supporting cells, Invitrogen Ccnd1 antibody (LabVision/Thermo Scientific, RM-9104) was used in immunohistochemistry on mouse samples at 1:250 (fig 2). PLoS ONE (2011) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:100
  • western blot; mouse; 1:1000
In order to study the role of hepatitis B virus in murine hepatocarcinogenesis, Invitrogen Ccnd1 antibody (Lab Vision, RM9104) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 and in western blot on mouse samples at 1:1000. PLoS ONE (2011) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 5
In order to identify the iNOS-NO pathway as a novel mediator of mitogenic Rac1 signaling, Invitrogen Ccnd1 antibody (NeoMarkers, 9104-S1) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5). J Cell Sci (2011) ncbi
mouse monoclonal (DCS-6)
  • immunocytochemistry; human; 1:100; fig 4
In order to study the immunohistochemical localization of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta, Invitrogen Ccnd1 antibody (Biosource, AHF0082) was used in immunocytochemistry on human samples at 1:100 (fig 4). Histochem Cell Biol (2011) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - frozen section; mouse; fig 2
In order to study a mouse model that allows tamoxifen-inducible somatic activation of oncogenic K-ras in a wide range of tissues, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104) was used in immunohistochemistry - frozen section on mouse samples (fig 2). J Pathol (2011) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1, 2, 3
  • immunohistochemistry; human; 1:100
In order to report on four cases of idiopathic cervical fibrosis, Invitrogen Ccnd1 antibody (Neomarkers, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1, 2, 3) and in immunohistochemistry on human samples at 1:100. Am J Surg Pathol (2010) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss factors that influence heat-induced antigen retrieval, Invitrogen Ccnd1 antibody (Labvision, SP4) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Pathology (2010) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; fig 3
In order to study the significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas, Invitrogen Ccnd1 antibody (Neomarkers, SP4) was used in immunohistochemistry on human samples (fig 3). Clin Cancer Res (2009) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:250; fig 2
In order to investigate the cellular effects of chlorophyllin treatment, Invitrogen Ccnd1 antibody (Biosource, DCS-6) was used in western blot on human samples at 1:250 (fig 2). Int J Cancer (2009) ncbi
domestic rabbit recombinant (SP4)
  • western blot; human; fig s4
In order to assess the sensitivity of 18 squamous cell carcinoma of the head and neck cell lines to gefitinib, Invitrogen Ccnd1 antibody (Neomarkers, RM-9104) was used in western blot on human samples (fig s4). J Pathol (2009) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; fig 1
  • immunohistochemistry; human
In order to investigate the parameters for the identification of multiple myeloma patients suitable for bortezomib therapy, Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in immunohistochemistry on human samples . Clin Cancer Res (2009) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
In order to screen for compounds that suppress cyclin D2 promoter transcription, Invitrogen Ccnd1 antibody (BioSource, DCS-6) was used in western blot on human samples . Blood (2009) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:50
In order to correlate histological subtypes and survival of B-cell lymphomas, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:50. Leuk Lymphoma (2008) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 6
In order to investigate the role of Notch signaling in lens development, Invitrogen Ccnd1 antibody (Neomarkers, SP4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 6). Dev Biol (2008) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
In order to examine if EGF-R contributes to the hydrocortisone and indomethacin-induced intestinal perforations of preterm infants, Invitrogen Ccnd1 antibody (NeoMarkers, DCS6) was used in western blot on human samples . Pediatr Res (2007) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; fig 1
In order to elucidate the relevance of cyclin D1 to early stage human breast cancer, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples (fig 1). Am J Surg Pathol (2007) ncbi
mouse monoclonal (DCS-6)
  • western blot; rat; 1:150; fig 3
In order to study the mechanism of thrombin-induced apoptosis in cultured cortical neurons, Invitrogen Ccnd1 antibody (Biosource, AHF0082) was used in western blot on rat samples at 1:150 (fig 3). J Neurochem (2007) ncbi
mouse monoclonal (AM29)
  • western blot; human; 1.1 ug/ml; fig 4
In order to elucidate how Neisseria gonorrhoeae affects the cell cycle of human cells, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in western blot on human samples at 1.1 ug/ml (fig 4). FASEB J (2007) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry; human; 1:50; fig 2
In order to investigate the therapeutic targeting of FGFR1 in lobular breast carcinomas, Invitrogen Ccnd1 antibody (LabVision, SP4) was used in immunohistochemistry on human samples at 1:50 (fig 2). Clin Cancer Res (2006) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the role of p14, p16, p53, cyclin D1, steroid hormone receptors, and human papillomaviruses infection in primary endometrial squamous cell carcinoma pathogenesis, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Diagn Pathol (2006) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - frozen section; mouse
In order to characterize targeting of GFP to newborn rods by temporal expression profiling of flow-sorted photoreceptors and Nrl promoter, Invitrogen Ccnd1 antibody (Zymed, noca) was used in immunohistochemistry - frozen section on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; fig 2
In order to examine the cell kinetics of ulcerative colitis-associated dysplasia and compare it to sporadic tubular adenoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples (fig 2). Pathol Int (2006) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry; human; tbl 1
In order to describe a case of pseudopapillary tumor of the pancreas, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry on human samples (tbl 1). Pathol Int (2005) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry; human
In order to discuss genes and mutations that contribute to medulloblastoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry on human samples . Genes Dev (2005) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:15
In order to study the immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:15. Am J Clin Pathol (2005) ncbi
domestic rabbit recombinant (SP4)
  • immunohistochemistry - paraffin section; human; 1:40
  • immunohistochemistry; human; 1:15
In order to study the immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, Invitrogen Ccnd1 antibody (Lab Vision, SP4) was used in immunohistochemistry - paraffin section on human samples at 1:40 and in immunohistochemistry on human samples at 1:15. Am J Clin Pathol (2005) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; mouse; 1:500
  • western blot; mouse
In order to study inulin-induced early biochemical changes in the normal-appearing mucosa, Invitrogen Ccnd1 antibody (Zymed, 33-3500) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 and in western blot on mouse samples . J Nutr Biochem (2005) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; fig 3
In order to study the relationship between the expression of thymidylate synthase, p16(INK4a), CDK4, and cyclin D1 and the effect of 5-FU-based chemotherapy in colorectal cancers, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples (fig 3). Pathol Int (2004) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:800; fig 5
In order to characterize the histopathology of pharmacologically-induced regressed cutaneous Kaposi's sarcoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 5). J Cutan Pathol (2004) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to review cases of ocular adnexal lymphoproliferative disorders, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Pathol Int (2004) ncbi
mouse monoclonal (AM29)
  • western blot; mouse; 1:500; fig 4
In order to study wnt signaling in embryonic stem cells, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in western blot on mouse samples at 1:500 (fig 4). Mol Cell Neurosci (2003) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to examine the relationships between cyclin D1 expression, beta catenin/k-ras status, and clinicopathological parameters in carcinoma of the ampulla of Vater, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Mol Pathol (2003) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to discuss CD23+ mantle cell lymphoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Am J Clin Pathol (2003) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to investigate loss of Rb function in neuroendocrine lung tumors, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Hum Pathol (2003) ncbi
mouse monoclonal (DCS-6)
  • western blot; rat; 1:200; loading ...; fig 1b
In order to study the role of STAT5 in transcriptional induction of the cyclin D2 gene and proliferation of rat pancreatic beta-cells, Invitrogen Ccnd1 antibody (Neo Markers, MS-215) was used in western blot on rat samples at 1:200 (fig 1b). Mol Endocrinol (2003) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to examine various markers for their prognostic value in ovarian carcinoma samples, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Am J Clin Pathol (2002) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:20
In order to study the immunophenotypes of small B-cell neoplasms using different sources of B cells, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:20. Am J Clin Pathol (2002) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 6
In order to study the mechanism by which rapamycin potentiates TGFbeta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells, Invitrogen Ccnd1 antibody (Neomarkers, DCS-6) was used in western blot on human samples (fig 6). Mol Cell Biol (2002) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to examine the role of cell-cycle regulators in the pathogenesis of acquired immune deficiency syndrome-related non-Hodgkin's lymphomas, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Am J Pathol (2002) ncbi
mouse monoclonal (AM29)
  • western blot; human; fig 5
In order to describe the human protein Drf1, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in western blot on human samples (fig 5). EMBO J (2002) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; fig 5
In order to investigate the t(11;14) chromosomal translocation, Invitrogen Ccnd1 antibody (Zymed, clone AM29) was used in immunohistochemistry - paraffin section on human samples (fig 5). J Pathol (2002) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:20
In order to report that CD10 is specific for diagnosis of follicular lymphoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:20. Am J Clin Pathol (2002) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:15
In order to characterize mantle cell lymphoma using patient samples, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:15. Mod Pathol (2001) ncbi
mouse monoclonal (AM29)
  • western blot; human; fig 2a
In order to elucidate Src- and PI3-kinase-dependent pathways in oestradiol-treated cells, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in western blot on human samples (fig 2a). EMBO J (2001) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human; 1:75
In order to characterize large cell transformation of chronic lymphocytic leukemia/small lymphocytic lymphomas using flow cytometry, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples at 1:75. Am J Clin Pathol (2001) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; human
In order to examine large and small CD5+ B-cell lymphomas, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunohistochemistry - paraffin section on human samples . Am J Clin Pathol (2000) ncbi
mouse monoclonal (AM29)
  • immunocytochemistry; human
In order to study the role of p27 in primary effusion lymphoma, Invitrogen Ccnd1 antibody (Zymed, AM29) was used in immunocytochemistry on human samples . Am J Pathol (2000) ncbi
mouse monoclonal (AM29)
  • immunohistochemistry - paraffin section; mouse; fig 2
In order to investigate the Rb pathway in murine T cell lymphomas, Invitrogen Ccnd1 antibody (Zymed, clone AM29) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Carcinogenesis (1999) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 5a, 5b
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:1000 (fig 5a, 5b). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig s2
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig s2). Cancers (Basel) (2022) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 1b, 2a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 1b, 2a). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c, 6c
Cell Signaling Technology Ccnd1 antibody (CST, 2922S) was used in western blot on human samples (fig 4c, 6c). J Cancer (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on human samples (fig 2f). Mol Cancer (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; fig 5c
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:1000 (fig 5c). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 5a). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples at 1:1000 (fig 3b). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3e
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on human samples (fig s3e). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry; human; loading ...; fig 4f
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in immunohistochemistry on human samples (fig 4f) and in western blot on human samples (fig 2d). iScience (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 6a). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 6b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 6b). Neural Regen Res (2022) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:700; loading ...; fig 2
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:700 (fig 2). Int J Endocrinol (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig s5a, s5b
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 5e
  • western blot; mouse; 1:1000; loading ...; fig 4d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig s5a, s5b), in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 5e) and in western blot on mouse samples at 1:1000 (fig 4d). NPJ Breast Cancer (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 3g, 3h
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:1000 (fig 3g, 3h). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (CST, 92G2) was used in western blot on human samples (fig 5a). Breast Cancer Res (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 2e). Cell Rep (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig s10a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig s10a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 5c). Cell Death Discov (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 5c
Cell Signaling Technology Ccnd1 antibody (CST, 2978T) was used in western blot on human samples (fig 5c). JCI Insight (2021) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 92G2) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 7g
Cell Signaling Technology Ccnd1 antibody (Cell signaling Technology, 92G2) was used in western blot on human samples at 1:1000 (fig 7g). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2922) was used in western blot on human samples (fig 4g). Diabetes (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2922) was used in western blot on human samples (fig 4). Dev Reprod (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples . J Clin Invest (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig s4c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978S) was used in western blot on human samples (fig s4c). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 2f
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 92G2) was used in western blot on mouse samples (fig 2f). BMC Cancer (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 4c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978T) was used in western blot on mouse samples (fig 4c). Drug Metab Dispos (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 6i
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:1000 (fig 6i). Cancer Cell Int (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on human samples (fig 4c). Front Cell Dev Biol (2020) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry; mouse; loading ...; fig 4a
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978S) was used in immunohistochemistry on mouse samples (fig 4a) and in western blot on mouse samples at 1:1000 (fig 4b). J Clin Invest (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, #2922) was used in western blot on mouse samples at 1:1000 (fig 3e). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 5c). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; rat; 1:1000; loading ...; fig 4f
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on rat samples at 1:1000 (fig 4f). Endocr Connect (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 2d). Int J Mol Sci (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 3g, h
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on mouse samples (fig 3g, h). Cancer Med (2020) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; rat; 1:400; loading ...; fig 9a
  • western blot; rat; loading ...; fig 7a
  • western blot; human; loading ...; fig 10a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978T) was used in immunohistochemistry - paraffin section on rat samples at 1:400 (fig 9a), in western blot on rat samples (fig 7a) and in western blot on human samples (fig 10a). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 3b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on mouse samples (fig 3b). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 3d). J Cancer (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples at 1:1000 (fig 5a). Int J Mol Med (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 4g). Mol Oncol (2020) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 1a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 7g, s7b
Cell Signaling Technology Ccnd1 antibody (CST, 2978T) was used in western blot on mouse samples at 1:1000 (fig 7g, s7b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 5b). Sci Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2h
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on mouse samples at 1:1000 (fig 2h). elife (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples (fig 3d). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 4h
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples (fig 4h). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:2000; loading ...; fig 7e
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples at 1:2000 (fig 7e). Biomolecules (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig 5b). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 4b). elife (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:2000; loading ...; fig 3d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978S) was used in western blot on human samples at 1:2000 (fig 3d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 7c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 7c). Int J Oncol (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5l
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on mouse samples (fig 5l). Aging Cell (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 5a). Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology Ccnd1 antibody (CST, 2922) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922S) was used in western blot on human samples (fig 1b). Oncogene (2019) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Cancer Res (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 92G2) was used in western blot on human samples (fig 3a). Mol Oncol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s8c, s8d
  • western blot; mouse; loading ...; fig s8b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig s8c, s8d) and in western blot on mouse samples (fig s8b). Hepatology (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4m
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on mouse samples at 1:1000 (fig 4m). Mol Psychiatry (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig s6e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig s6e). Cell (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 4e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 4e). Cancer Lett (2019) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 7b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978S) was used in western blot on mouse samples at 1:1000 (fig 7b). Int J Biol Macromol (2018) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
  • western blot; mouse; loading ...; fig 3b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a) and in western blot on mouse samples (fig 3b). Mol Cancer Res (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 5c). Cell Death Dis (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3f
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2922) was used in western blot on mouse samples at 1:500 (fig 3f). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 4a). Am J Transl Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2922) was used in western blot on human samples (fig 4a). Oncogene (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 7b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig 7b). Oncotarget (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot knockout validation; mouse; loading ...; fig 2a
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot knockout validation on mouse samples (fig 2a) and in western blot on human samples (fig 2c). Nature (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 2c). Clin Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 5j, 5k, 5l
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples at 1:2000 (fig 5j, 5k, 5l). Gut (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 92G2) was used in western blot on human samples (fig 5c). EBioMedicine (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 2h
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig 2h). Cancer Res (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 5). Exp Neurol (2018) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 6
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 6). Oncol Rep (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 7a
In order to propose a potential effect of Hylomecon vernalis Maxim ethanol extracts for treating colorectal cancer, Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978S) was used in western blot on human samples at 1:1000 (fig 7a). Mol Med Rep (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:500; loading ...; fig 3a
In order to elucidate the mechanism of Pin1 overexpression in hepatocellular carcinoma, Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978 S) was used in western blot on human samples at 1:500 (fig 3a). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2922) was used in western blot on human samples at 1:1000 (fig 3c). Am J Cancer Res (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig 5a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; rat; loading ...; fig 13a
Cell Signaling Technology Ccnd1 antibody (cell signalling, 2978) was used in western blot on rat samples (fig 13a). Am J Pathol (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 4a
In order to examine the impact of recruited CD8+ T cells on BPH epithelial cells under a low androgen level, Cell Signaling Technology Ccnd1 antibody (cell signalling, 2978) was used in western blot on human samples at 1:1000 (fig 4a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry; mouse; 1:50; fig 7w
In order to examine the expression pattern and functional significance of Wnt5a in cerebellar development, Cell Signaling Technology Ccnd1 antibody (Cell Signalling, 2978) was used in immunohistochemistry on mouse samples at 1:50 (fig 7w). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 3D
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on rat samples at 1:1000 (fig 3D). Int J Mol Med (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s7f
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig s7f). Arterioscler Thromb Vasc Biol (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 4A
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples (fig 4A). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 7a
In order to study the interaction between Hap1 and Dcaf7, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 7a). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig s3b
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples (fig s3b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 3a). Oncol Lett (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...
In order to identify key differences in Brm- and Brg1-specific SWI/SNF complexes, Cell Signaling Technology Ccnd1 antibody (cell signalling, 2978P) was used in western blot on human samples at 1:1000. Oncoscience (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig s2
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig s2). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 2d). FEBS Open Bio (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 4a
In order to examine the role of the E2F pathway in cardiac metabolism, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 4a). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - frozen section; mouse; 1:700; loading ...; fig 11f
  • western blot; mouse; 1:700; loading ...; fig 11a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in immunohistochemistry - frozen section on mouse samples at 1:700 (fig 11f) and in western blot on mouse samples at 1:700 (fig 11a). J Neurosci (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 4c
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 4c). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; loading ...; fig 3
Cell Signaling Technology Ccnd1 antibody (cell signalling, 2978) was used in western blot on mouse samples at 1:1000 (fig 3). Oncotarget (2017) ncbi
domestic rabbit monoclonal (92G2)
  • immunocytochemistry; human; loading ...; fig 5d
  • western blot; human; loading ...; fig 7c
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in immunocytochemistry on human samples (fig 5d) and in western blot on human samples (fig 7c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot knockout validation; mouse; loading ...; fig 3b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot knockout validation on mouse samples (fig 3b). Mol Pharmacol (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1500; loading ...; fig 4b
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples at 1:1500 (fig 4b). Cell Cycle (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 4
In order to explore the role of NLS-RARalpha in acute promyelocytic leukemia, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 4g
  • western blot; mouse; 1:1000; loading ...; fig s2b
In order to demonstrate that Fat1 cadherin represses mitochondrial respiration that regulates vascular smooth muscle cell proliferation after arterial injury, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978S) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4g) and in western blot on mouse samples at 1:1000 (fig s2b). Nature (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 5a). Int J Mol Sci (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:2000; loading ...; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:2000 (fig 5c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 2g
In order to show that that MSI2 directly regulates estrogen receptor 1 in breast cancer cells, Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; fig 5c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples at 1:1000 (fig 5c). Cancer Chemother Pharmacol (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 6). Stem Cell Reports (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3c
In order to evaluate the effect of glucocorticoids in a mouse model of colitis, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on mouse samples at 1:1000 (fig 3c). Biochem Pharmacol (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 5c
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 5c). J Proteomics (2017) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 2h
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on human samples (fig 2h). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3
In order to analyze the rescue of intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation due to ERK5 signaling, Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2922) was used in western blot on mouse samples (fig 3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; fig 1
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples (fig 1). Cell Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Tech, 2922) was used in western blot on human samples at 1:1000 (fig 6). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:500; fig 8e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:500 (fig 8e). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; fig 7
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on mouse samples (fig 7). Cardiovasc Res (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 8
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on human samples (fig 8). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:500; fig 4
Cell Signaling Technology Ccnd1 antibody (CST, 2978) was used in western blot on mouse samples at 1:500 (fig 4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 1e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples at 1:1000 (fig 5a). Onco Targets Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 4d). Sci Rep (2016) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; baboons; fig 5
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in immunohistochemistry - paraffin section on baboons samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 3
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 4
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Tech, 2978S) was used in western blot on human samples (fig 4). Sci Signal (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; rat; fig 5
In order to determine regulation of global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha by the small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives, Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2978) was used in western blot on rat samples (fig 5). Cell Stress Chaperones (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 4). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig s4
Cell Signaling Technology Ccnd1 antibody (Cell signaling, 2922) was used in western blot on mouse samples at 1:500 (fig s4). J Bone Miner Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to characterize an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications defined by PLEKHA7, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 4). Cell Cycle (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; fig 4
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Tech, 2978) was used in western blot on mouse samples (fig 4). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples . Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
In order to present liposomal c8 ceramide as a potent anti-hepatocellular carcinoma agent, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2922) was used in western blot on human samples (fig 4a). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples at 1:1000 (fig 4b). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 3b
In order to study MARCKS signaling and how it expresses endothelial cell proliferation and vascular smooth muscle through a KIS-, p27kip1- dependent mechanism, Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig 3b). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 8
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 8). Oncotarget (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; fig 5
  • western blot; human; fig 5
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on mouse samples (fig 5) and in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 6
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978s) was used in western blot on human samples (fig 6). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978s) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Oncogene (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 2e
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 2e). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; loading ...; fig 6b
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 6b). Neuroendocrinology (2016) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; mouse; 1:1000; fig 5h
In order to determine role of CaMKIIdelta in cardiac progenitor cells, Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on mouse samples at 1:1000 (fig 5h). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 3
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Tech, 92G2) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry; mouse; loading ...; fig 3
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in immunohistochemistry on mouse samples (fig 3). Cell Death Differ (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; 1:500
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, #2978) was used in western blot on human samples at 1:500. Br J Pharmacol (2015) ncbi
domestic rabbit monoclonal (92G2)
  • immunohistochemistry - paraffin section; mouse; 1:50
  • western blot; human; fig 4
In order to study the molecular mechanisms underlying malignant changes of meningioma cells, Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 and in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig 1
Cell Signaling Technology Ccnd1 antibody (Cell Signaling, 2978) was used in western blot on human samples (fig 1). Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (92G2)
  • other; human; loading ...; fig 5b
  • western blot; human; loading ...; fig 5c,6d
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology Inc., 2978) was used in other on human samples (fig 5b) and in western blot on human samples (fig 5c,6d). Mol Carcinog (2015) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human
Cell Signaling Technology Ccnd1 antibody (Cell, 92G2) was used in western blot on human samples . BMC Cancer (2014) ncbi
domestic rabbit monoclonal (92G2)
  • western blot; human; fig S7
Cell Signaling Technology Ccnd1 antibody (Cell Signaling Technology, 2978) was used in western blot on human samples (fig S7). PLoS ONE (2014) ncbi
Biocare Medical
monoclonal (SP4)
  • immunocytochemistry; mouse; loading ...; fig 5a
Biocare Medical Ccnd1 antibody (Biocare Medical, CRM307AK) was used in immunocytochemistry on mouse samples (fig 5a). Gastroenterology (2018) ncbi
BD Biosciences
mouse monoclonal (G124-326)
  • western blot; human; 1:500; fig 2
  • western blot; mouse; 1:500; fig 5
BD Biosciences Ccnd1 antibody (BD Biosciences, 554180) was used in western blot on human samples at 1:500 (fig 2) and in western blot on mouse samples at 1:500 (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (G124-326)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences Ccnd1 antibody (BD, G124-326) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (G124-326)
  • western blot; human
BD Biosciences Ccnd1 antibody (Biosciences Pharmingen, G124-326) was used in western blot on human samples . Nucleic Acids Res (2013) ncbi
MilliporeSigma
mouse monoclonal (DCS-6)
  • western blot; human; fig 6
In order to determine how cytosolic phospholipase A2alpha prohibits prostate cancer cells from re-entering the cell cyle, MilliporeSigma Ccnd1 antibody (Sigma-Aldrich, C7464) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:200; fig 6
MilliporeSigma Ccnd1 antibody (Sigma, C 7464) was used in western blot on human samples at 1:200 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; rat; loading ...; fig 3
MilliporeSigma Ccnd1 antibody (Sigma, C7464) was used in western blot on rat samples (fig 3). Biomed Res Int (2014) ncbi
Articles Reviewed
  1. Bahn M, Yu D, Lee M, Jo S, Lee J, Kim H, et al. Central role of Prominin-1 in lipid rafts during liver regeneration. Nat Commun. 2022;13:6219 pubmed publisher
  2. Aboouf M, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, et al. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher
  3. Hu S, Liu S, Bian Y, Poddar M, Singh S, Cao C, et al. Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep Med. 2022;3:100754 pubmed publisher
  4. Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
  5. Cai S, Hu T, Venkatesan M, Allam M, Schneider F, Ramalingam S, et al. Multiplexed protein profiling reveals spatial subcellular signaling networks. iScience. 2022;25:104980 pubmed publisher
  6. Lei T, Zhang W, He Y, Wei S, Song X, Zhu Y, et al. ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway. Cell Death Dis. 2022;13:781 pubmed publisher
  7. Jiang L, Li D, Wang C, Liao J, Liu J, Wei Q, et al. Decreased Expression of Karyopherin-α 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the Proliferation of Hela Cells. Pathol Oncol Res. 2022;28:1610518 pubmed publisher
  8. Tang Y, Dong L, Zhang C, Li X, Li R, Lin H, et al. PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis. Int J Biol Sci. 2022;18:4329-4340 pubmed publisher
  9. Malanga D, Laudanna C, Mirante T, Colelli F, Migliozzi S, Zoppoli P, et al. The AKT1E17K Allele Promotes Breast Cancer in Mice. Cancers (Basel). 2022;14: pubmed publisher
  10. Chen J, Chen K, Wang L, Luo J, Zheng Q, He Y. Decoy receptor 2 mediates the apoptosis-resistant phenotype of senescent renal tubular cells and accelerates renal fibrosis in diabetic nephropathy. Cell Death Dis. 2022;13:522 pubmed publisher
  11. Ka N, Lim G, Kim S, Hwang S, Han J, Lee Y, et al. Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer. Cell Mol Life Sci. 2022;79:306 pubmed publisher
  12. Cyra M, Schulte M, Berthold R, Heinst L, Jansen E, Gr xfc newald I, et al. SS18-SSX drives CREB activation in synovial sarcoma. Cell Oncol (Dordr). 2022;45:399-413 pubmed publisher
  13. Chen X, Huang Y, Liu J, Lin W, Chen C, Chen Y, et al. EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. J Cancer. 2022;13:1456-1467 pubmed publisher
  14. Shen M, Zhang R, Jia W, Zhu Z, Zhao L, Huang G, et al. RNA-binding protein p54nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer. Cell Death Dis. 2022;13:42 pubmed publisher
  15. Méndez Solís O, Bendjennat M, Naipauer J, Theodoridis P, Ho J, Verdun R, et al. Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis. Cell Rep. 2021;37:110144 pubmed publisher
  16. Zou J, Pei X, Xing D, Wu X, Chen S. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. J Cell Mol Med. 2021;25:9826-9836 pubmed publisher
  17. Liu X, Liu Y, Liu Z, Lin C, Meng F, Xu L, et al. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner. Mol Cancer. 2021;20:114 pubmed publisher
  18. Huang J, Xiao R, Wang X, Khadka B, Fang Z, Yu M, et al. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2. Int J Oncol. 2021;59: pubmed publisher
  19. Mygland L, Brinch S, Strand M, Olsen P, Aizenshtadt A, Lund K, et al. Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. iScience. 2021;24:102807 pubmed publisher
  20. Giuliani V, Miller M, Liu C, Hartono S, Class C, Bristow C, et al. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun. 2021;12:4626 pubmed publisher
  21. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  22. Chen H, Padia R, Li T, Li Y, Li B, Jin L, et al. Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1. NPJ Breast Cancer. 2021;7:91 pubmed publisher
  23. Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, et al. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer. Clin Transl Med. 2021;11:e454 pubmed publisher
  24. Luo C, Xu X, Liu C, He S, Chen J, Feng Y, et al. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis. Adv Sci (Weinh). 2021;8:e2004852 pubmed publisher
  25. Low J, Du W, Gocha T, Oguz G, Zhang X, Chen M, et al. Molecular docking-aided identification of small molecule inhibitors targeting β-catenin-TCF4 interaction. iScience. 2021;24:102544 pubmed publisher
  26. Zhu J, Cai T, Zhou J, Du W, Zeng Y, Liu T, et al. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. J Exp Clin Cancer Res. 2021;40:192 pubmed publisher
  27. Wang R, Yang D, Liu Y, Ding J, Guo Y, Ding W, et al. Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury. Neural Regen Res. 2022;17:130-136 pubmed publisher
  28. Lee J, Hsu Y, Li Y, Cheng S. Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells. Int J Endocrinol. 2021;2021:5583491 pubmed publisher
  29. Li H, Kurtzeborn K, Kupari J, Gui Y, Siefker E, Lu B, et al. Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF. Development. 2021;148: pubmed publisher
  30. Wojnarowicz P, Escolano M, Huang Y, Desai B, Chin Y, Shah R, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021;7:58 pubmed publisher
  31. Wang K, Ding Y, Xu C, Hao M, Li H, Ding L. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity. Oncoimmunology. 2021;10:1923910 pubmed publisher
  32. Li X, Lin P, Tao Y, Jiang X, Li T, Wang Y, et al. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Front Cell Dev Biol. 2021;9:661122 pubmed publisher
  33. Hsieh M, Weng C, Lin Y, Wu C, Chen L, Cheng K. Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice. Int J Mol Sci. 2021;22: pubmed publisher
  34. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  35. Cao X, Shu Y, Chen Y, Xu Q, Guo G, Wu Z, et al. Mettl14-Mediated m6A Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum Homeostasis. Cell Mol Gastroenterol Hepatol. 2021;12:633-651 pubmed publisher
  36. Zhu X, Chen L, Huang B, Li X, Yang L, Hu X, et al. Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer. J Exp Clin Cancer Res. 2021;40:122 pubmed publisher
  37. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  38. Nishad R, Mukhi D, Singh A, Motrapu M, Chintala K, Tammineni P, et al. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021;12:342 pubmed publisher
  39. Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L, et al. CREB1 acts via the miR‑922/ARID2 axis to enhance malignant behavior of liver cancer cells. Oncol Rep. 2021;45: pubmed publisher
  40. Yin Y, Zhou N, Zhang H, Dai X, Lv X, Chen N, et al. Bmi1 regulate tooth and mandible development by inhibiting p16 signal pathway. J Cell Mol Med. 2021;25:4195-4203 pubmed publisher
  41. Xiao Z, Yang X, Liu Z, Shao Z, Song C, Zhang K, et al. GASC1 promotes glioma progression by enhancing NOTCH1 signaling. Mol Med Rep. 2021;23: pubmed publisher
  42. Kaminska K, Akrap N, Staaf J, Alves C, Ehinger A, Ebbesson A, et al. Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer. Breast Cancer Res. 2021;23:26 pubmed publisher
  43. Zhu C, Kim S, Mooradian A, Wang F, Li Z, Holohan S, et al. Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1. Cell Rep. 2021;34:108749 pubmed publisher
  44. Wu Y, Cao Y, Xu K, Zhu Y, Qiao Y, Wu Y, et al. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis. Cell Death Dis. 2021;12:163 pubmed publisher
  45. Chi R, van der Watt P, Wei W, Birrer M, Leaner V. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer. BMC Cancer. 2021;21:106 pubmed publisher
  46. Buitrago Molina L, Marhenke S, Becker D, Geffers R, Itzel T, Teufel A, et al. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model. Cell Mol Gastroenterol Hepatol. 2021;11:1387-1404 pubmed publisher
  47. Blanc V, Riordan J, Soleymanjahi S, Nadeau J, Nalbantoglu I, Xie Y, et al. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. J Clin Invest. 2021;131: pubmed publisher
  48. Roliński M, Montaldo N, Aksu M, Fordyce Martin S, Brambilla A, Kunath N, et al. Loss of Mediator complex subunit 13 (MED13) promotes resistance to alkylation through cyclin D1 upregulation. Nucleic Acids Res. 2021;: pubmed publisher
  49. Peng D, Lin B, Xie M, Zhang P, Guo Q, Li Q, et al. Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor. Cell Death Discov. 2021;7:9 pubmed publisher
  50. Ye S, Sharipova D, Kozinova M, Klug L, D Souza J, Belinsky M, et al. Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment. JCI Insight. 2021;6: pubmed publisher
  51. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  52. Ruan H, Li X, Xu X, Leibowitz B, Tong J, Chen L, et al. eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis. elife. 2020;9: pubmed publisher
  53. Liu W, Li J, Zhang D, Chen B, Wang X, Zhang X, et al. Trefoil factor 1 and gastrokine 2 inhibit Helicobacter pylori-induced proliferation and inflammation in gastric cardia and distal carcinogenesis. Oncol Lett. 2020;20:318 pubmed publisher
  54. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed publisher
  55. Zhang Y, Zhang L, Lu S, Xiang Y, Zeng C, He T, et al. Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Res Treat. 2021;53:184-198 pubmed publisher
  56. Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, et al. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU. Int J Mol Med. 2020;46:1683-1694 pubmed publisher
  57. Chen K, Jiao X, Di Rocco A, Shen D, Xu S, Ertel A, et al. Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation. Cell Rep. 2020;32:108151 pubmed publisher
  58. Liu C, Teo M, Pek S, Wu X, Leong M, Tay H, et al. A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions. Diabetes. 2020;69:2467-2480 pubmed publisher
  59. Sun R, Hedl M, Abraham C. TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants. Cell Mol Gastroenterol Hepatol. 2021;11:249-272 pubmed publisher
  60. Chen J, Liu X, Ke K, Zou J, Gao Z, Habuchi T, et al. LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression. BMC Cancer. 2020;20:749 pubmed publisher
  61. Lee S, Hong K, Seong Y, Kwak S. Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS Cells. Dev Reprod. 2020;24:101-111 pubmed publisher
  62. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher
  63. Yu W, Hua Y, Qiu H, Hao J, Zou K, Li Z, et al. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death Dis. 2020;11:506 pubmed publisher
  64. Kuo I, Lee J, Wang Y, Chiang H, Huang C, Hsieh P, et al. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia. BMC Cancer. 2020;20:603 pubmed publisher
  65. Jiao T, Yao X, Zhao Y, Zhou Y, Gao Y, Fan S, et al. Dexamethasone-Induced Liver Enlargement Is Related to PXR/YAP Activation and Lipid Accumulation but Not Hepatocyte Proliferation. Drug Metab Dispos. 2020;48:830-839 pubmed publisher
  66. Lin Z, Lin X, Zhu L, Huang J, Huang Y. TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma. Cancer Cell Int. 2020;20:228 pubmed publisher
  67. Yin S, Song M, Zhao R, Liu X, Kang W, Lee J, et al. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo. Front Cell Dev Biol. 2020;8:366 pubmed publisher
  68. Du Z, Dong J, Li M, Zhang J, Bi J, Ren Y, et al. Overexpression of Platelet-Derived Growth Factor Receptor Α D842V Mutants Prevents Liver Regeneration and Chemically Induced Hepatocarcinogenesis via Inhibition of MET and EGFR. J Cancer. 2020;11:4614-4624 pubmed publisher
  69. Di Matteo F, Pipicelli F, Kyrousi C, Tovecci I, Penna E, Crispino M, et al. Cystatin B is essential for proliferation and interneuron migration in individuals with EPM1 epilepsy. EMBO Mol Med. 2020;12:e11419 pubmed publisher
  70. Alajati A, D Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, et al. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. J Clin Invest. 2020;130:2435-2450 pubmed publisher
  71. Ceccarelli M, D Andrea G, Micheli L, Tirone F. Deletion of Btg1 Induces Prmt1-Dependent Apoptosis and Increased Stemness in Shh-Type Medulloblastoma Cells Without Affecting Tumor Frequency. Front Oncol. 2020;10:226 pubmed publisher
  72. Zhang J, Huang J, Zhang Y, Zhang X, Zhao L, Li C, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine. 2020;53:102701 pubmed publisher
  73. Zang M, Guo J, Liu L, Jin F, Feng X, An G, et al. Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. Oncogenesis. 2020;9:31 pubmed publisher
  74. Hu J, Chen Q, Ding X, Zheng X, Tang X, Li S, et al. Glutamine metabolism in the proliferation of GS-expression pituitary tumor cells. Endocr Connect. 2020;: pubmed publisher
  75. Hindupur S, Schmid S, Koch J, Youssef A, Baur E, Wang D, et al. STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy. Int J Mol Sci. 2020;21: pubmed publisher
  76. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  77. Gu Y, Zhu Z, Pei H, Xu D, Jiang Y, Zhang L, et al. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging (Albany NY). 2020;12:2333-2346 pubmed publisher
  78. Zuo J, Zhao M, Fan Z, Liu B, Wang Y, Li Y, et al. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. Thorac Cancer. 2020;11:738-747 pubmed publisher
  79. Ju L, Shan L, Yin B, Song Y. δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genes. Cancer Med. 2020;9:2201-2212 pubmed publisher
  80. Wang L, Xie J, Zhang H, Tsang L, Tsang S, Braune E, et al. Notch signalling regulates epibranchial placode patterning and segregation. Development. 2020;147: pubmed publisher
  81. Zhang Y, Mao X, Chen W, Guo X, Yu L, Jiang F, et al. A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation. Mol Ther Nucleic Acids. 2020;19:890-904 pubmed publisher
  82. Cui J, Duan J, Chu J, Guo C, Xi M, Li Y, et al. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway. Aging (Albany NY). 2020;12:1591-1609 pubmed publisher
  83. Liao S, Chen H, Liu M, Gan L, Li C, Zhang W, et al. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging (Albany NY). 2020;12:1527-1544 pubmed publisher
  84. Qiao H, Tan X, Lv D, Xing R, Shu F, Zhong C, et al. Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis. J Cancer. 2020;11:1027-1037 pubmed publisher
  85. Mlyczynska E, Kurowska P, Drwal E, Opydo Chanek M, Tworzydło W, Kotula Balak M, et al. Apelin and apelin receptor in human placenta: Expression, signalling pathway and regulation of trophoblast JEG‑3 and BeWo cells proliferation and cell cycle. Int J Mol Med. 2020;45:691-702 pubmed publisher
  86. Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol. 2019;19:230 pubmed publisher
  87. Tang L, Li J, Fu W, Wu W, Xu J. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo. Aging (Albany NY). 2019;11:11829-11843 pubmed publisher
  88. Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed publisher
  89. Patel H, Tao N, Lee K, Huerta M, Arlt H, Mullarkey T, et al. Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors. Breast Cancer Res. 2019;21:146 pubmed publisher
  90. Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681 pubmed publisher
  91. Guiley K, Stevenson J, Lou K, Barkovich K, Kumarasamy V, Wijeratne T, et al. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition. Science. 2019;366: pubmed publisher
  92. Si J, Ma Y, Bi J, Xiong Y, Lv C, Li S, et al. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. J Exp Clin Cancer Res. 2019;38:481 pubmed publisher
  93. Jiang K, Zhi X, Ma Y, Zhou L. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23:9890-9899 pubmed publisher
  94. Welk V, Meul T, Lukas C, Kammerl I, Mulay S, Schamberger A, et al. Proteasome activator PA200 regulates myofibroblast differentiation. Sci Rep. 2019;9:15224 pubmed publisher
  95. Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11:7830-7846 pubmed publisher
  96. Zhong B, Shi D, Wu F, Wang S, Hu H, Cheng C, et al. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Cell Death Dis. 2019;10:687 pubmed publisher
  97. Barbero G, Castro M, Villanueva M, Quezada M, Fernández N, Demorrow S, et al. An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma. Cells. 2019;8: pubmed publisher
  98. Piao L, Yang Z, Feng Y, Zhang C, Cui C, Xuan Y. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 2019;19:898 pubmed publisher
  99. Diaz Osterman C, Ozmadenci D, Kleinschmidt E, Taylor K, Barrie A, Jiang S, et al. FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy. elife. 2019;8: pubmed publisher
  100. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  101. Ji M, Wang Z, Chen J, Gu L, Chen M, Ding Y, et al. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin. Biosci Rep. 2019;39: pubmed publisher
  102. He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY). 2019;11:5744-5756 pubmed publisher
  103. Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
  104. Kim K, Rana A, Park C. Orai1 inhibitor STIM2β regulates myogenesis by controlling SOCE dependent transcriptional factors. Sci Rep. 2019;9:10794 pubmed publisher
  105. Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52:34 pubmed publisher
  106. Lee Y, Yeo I, Kim K, Han S, Hong J. Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity. Front Immunol. 2019;10:1379 pubmed publisher
  107. Roy N, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar N, Singh A, et al. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. Biomolecules. 2019;9: pubmed publisher
  108. Liu B, Zhang J, Yang D. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1. J Ovarian Res. 2019;12:57 pubmed publisher
  109. Wohlrab C, Kuiper C, Vissers M, Phillips E, Robinson B, Dachs G. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia (Auckl). 2019;7:17-31 pubmed publisher
  110. Yin M, Zhou H, Lin C, Long L, Yang X, Zhang H, et al. CD34+KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair. Cell Rep. 2019;27:2709-2724.e3 pubmed publisher
  111. Pietila M, Sahgal P, Peuhu E, Jäntti N, Paatero I, Närvä E, et al. SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nat Commun. 2019;10:2340 pubmed publisher
  112. Zhang C, Zhu Q, Gu J, Chen S, Li Q, Ying L. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Biosci Rep. 2019;39: pubmed publisher
  113. Shi K, Yin X, Cai M, Yan Y, Jia C, Ma P, et al. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors. elife. 2019;8: pubmed publisher
  114. Huang X, Xue H, Ma J, Zhang Y, Zhang J, Liu Y, et al. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity. J Cell Mol Med. 2019;23:4443-4453 pubmed publisher
  115. Udden S, Kwak Y, Godfrey V, Khan M, Khan S, Loof N, et al. NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte. elife. 2019;8: pubmed publisher
  116. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed publisher
  117. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  118. Yang H, Shen J, Wang Y, Liu Y, Shen D, Quan S. Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling. Biomed Res Int. 2019;2019:2686340 pubmed publisher
  119. Chen L, Yang R, Qiao W, Zhang W, Chen J, Mao L, et al. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling. Aging Cell. 2019;18:e12951 pubmed publisher
  120. Wang Z, Feng X, Molinolo A, Martin D, Vitale Cross L, Nohata N, et al. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res. 2019;: pubmed publisher
  121. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  122. SCHADE A, Oser M, Nicholson H, DeCaprio J. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB. Oncogene. 2019;38:4962-4976 pubmed publisher
  123. Fang G, Qi J, Huang L, Zhao X. LncRNA MRAK048635_P1 is critical for vascular smooth muscle cell function and phenotypic switching in essential hypertension. Biosci Rep. 2019;: pubmed publisher
  124. Zhang X, Qin Q, Dai H, Cai S, Zhou C, Guan J. Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression. Braz J Med Biol Res. 2019;52:e7994 pubmed publisher
  125. Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B, et al. F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function. J Pathol. 2019;248:266-279 pubmed publisher
  126. Su W, Wang Y, Wang F, Zhang B, Zhang H, Shen Y, et al. Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma. J Cell Physiol. 2019;: pubmed publisher
  127. Bishnupuri K, Alvarado D, Khouri A, Shabsovich M, Chen B, Dieckgraefe B, et al. IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis. Cancer Res. 2019;: pubmed publisher
  128. Ji Q, Xu X, Kang L, Xu Y, Xiao J, Goodman S, et al. Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis. Nat Commun. 2019;10:313 pubmed publisher
  129. Yang F, Fang E, Mei H, Chen Y, Li H, Li D, et al. Cis-Acting circ-CTNNB1 Promotes β-Catenin Signaling and Cancer Progression via DDX3-Mediated Transactivation of YY1. Cancer Res. 2019;79:557-571 pubmed publisher
  130. Zhang Z, Chen J, Huang W, Ning D, Liu Q, Wang C, et al. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma. Mol Oncol. 2019;13:792-810 pubmed publisher
  131. Wang Y, Du L, Liang X, Meng P, Bi L, Wang Y, et al. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice. Hepatology. 2018;: pubmed publisher
  132. Wang M, Tang C, Xing R, Liu X, Han X, Liu Y, et al. WDR81 regulates adult hippocampal neurogenesis through endosomal SARA-TGFβ signaling. Mol Psychiatry. 2018;: pubmed publisher
  133. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  134. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  135. Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
  136. Bugaj L, Sabnis A, Mitchell A, Garbarino J, Toettcher J, Bivona T, et al. Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway. Science. 2018;361: pubmed publisher
  137. Xu Y, Xu J, Ge K, Tian Q, Zhao P, Guo Y. Anti-inflammatory effect of low molecular weight fucoidan from Saccharina japonica on atherosclerosis in apoE-knockout mice. Int J Biol Macromol. 2018;118:365-374 pubmed publisher
  138. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed publisher
  139. Park J, Kim I, Choi J, Lim H, Shin J, Kim Y, et al. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res. 2018;16:1287-1298 pubmed publisher
  140. Huang G, Jiang H, Lin Y, Wu Y, Cai W, Shi B, et al. lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. Cell Death Dis. 2018;9:487 pubmed publisher
  141. Morgan E, Wasson C, Hanson L, Kealy D, Pentland I, McGuire V, et al. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathog. 2018;14:e1006975 pubmed publisher
  142. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed publisher
  143. Yang R, Tao Z, Huang M, Zheng Y, Dai M, Zou Y, et al. Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway. Am J Transl Res. 2018;10:455-464 pubmed
  144. Haller M, Au J, O Neill M, Lamb D. 16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A. 2018;115:E1849-E1858 pubmed publisher
  145. Shen L, Qu X, Li H, Xu C, Wei M, Wang Q, et al. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis. Oncogene. 2018;37:1759-1774 pubmed publisher
  146. He P, Yang J, Yang V, Bialkowska A. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology. 2018;154:1494-1508.e13 pubmed publisher
  147. Kim M, Morales L, Baek M, Slaga T, DiGiovanni J, Kim D. UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3? axis inhibits keratinocyte survival and proliferation. Oncotarget. 2017;8:90674-90692 pubmed publisher
  148. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  149. Huang C, Wu S, Ji H, Yan X, Xie Y, Murai S, et al. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library. Sci Adv. 2017;3:e1701383 pubmed publisher
  150. Zhao Z, Jia Q, Wu M, Xie X, Wang Y, Song G, et al. Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation-Mediated Repression of the Hedgehog/Gli1 Pathway. Clin Cancer Res. 2018;24:130-144 pubmed publisher
  151. Chong I, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, et al. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018;67:1780-1792 pubmed publisher
  152. Liu Z, Li H, Liu J, Wu M, Chen X, Liu L, et al. Inactivated Wnt signaling in resveratrol-treated epidermal squamous cancer cells and its biological implication. Oncol Lett. 2017;14:2239-2243 pubmed publisher
  153. Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530 pubmed publisher
  154. Capurro M, Izumikawa T, Suarez P, Shi W, Cydzik M, Kaneiwa T, et al. Glypican-6 promotes the growth of developing long bones by stimulating Hedgehog signaling. J Cell Biol. 2017;216:2911-2926 pubmed publisher
  155. Wang Q, Yu Y, Zhang P, Chen Y, Li C, Chen J, et al. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112:47 pubmed publisher
  156. Fell S, Li S, Wallis K, Kock A, Surova O, Rraklli V, et al. Neuroblast differentiation during development and in neuroblastoma requires KIF1B?-mediated transport of TRKA. Genes Dev. 2017;31:1036-1053 pubmed publisher
  157. Liang X, Yuan X, Yu J, Wu Y, Li K, Sun C, et al. Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes. EBioMedicine. 2017;21:104-116 pubmed publisher
  158. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  159. Oblinger J, Burns S, Huang J, Pan L, Ren Y, Shen R, et al. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol. 2018;299:299-307 pubmed publisher
  160. Kokabu S, Nakatomi C, Matsubara T, Ono Y, Addison W, Lowery J, et al. The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor. J Biol Chem. 2017;292:12885-12894 pubmed publisher
  161. Wang B, Gu Q, Li J. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway. Oncol Rep. 2017;38:317-324 pubmed publisher
  162. Read M, Fong J, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson R, et al. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. Oncogene. 2017;36:5296-5308 pubmed publisher
  163. He D, Ren B, Liu S, Tan L, Cieply K, Tseng G, et al. Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies. Oncogene. 2017;36:3629-3639 pubmed publisher
  164. Kapil S, Sharma B, Patil M, Elattar S, Yuan J, Hou S, et al. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget. 2017;8:26515-26531 pubmed publisher
  165. Sun J, Zhang X, Sun Y, Tang Z, Guo D. Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells. Mol Med Rep. 2017;15:3485-3492 pubmed publisher
  166. Yan X, Zhu Z, Xu S, Yang L, Liao X, Zheng M, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915 pubmed publisher
  167. Jiang J, Chen X, Liu H, Shao J, Xie R, Gu P, et al. Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM. Am J Cancer Res. 2017;7:245-259 pubmed
  168. Lee H, Kim M, Baek M, Morales L, Jang I, Slaga T, et al. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development. Sci Rep. 2017;7:45077 pubmed publisher
  169. Yu G, Zhang T, Jing Y, Bao Q, Tang Q, Zhang Y. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP. Life Sci. 2017;175:47-51 pubmed publisher
  170. Manzanares M, Usui A, Campbell D, Dumur C, Maldonado G, Fausther M, et al. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol. 2017;187:1068-1092 pubmed publisher
  171. Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X, et al. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity. Sci Rep. 2017;7:43771 pubmed publisher
  172. Yang Y, Hu S, Liu J, Cui Y, Fan Y, Lv T, et al. CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Sci Rep. 2017;7:42893 pubmed publisher
  173. Subashini C, Dhanesh S, Chen C, Riya P, Meera V, Divya T, et al. Wnt5a is a crucial regulator of neurogenesis during cerebellum development. Sci Rep. 2017;7:42523 pubmed publisher
  174. Wang N, Yao F, Li K, Zhang L, Yin G, Du M, et al. Fisetin regulates astrocyte migration and proliferation in vitro. Int J Mol Med. 2017;39:783-790 pubmed publisher
  175. He Y, Wang X, Zhang J, Liu Z, Pan W, Shen Y, et al. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs. Arterioscler Thromb Vasc Biol. 2017;37:717-729 pubmed publisher
  176. Whitaker A, Berthet E, Cantu A, Laird D, Alliston T. Smad4 regulates growth plate matrix production and chondrocyte polarity. Biol Open. 2017;6:358-364 pubmed publisher
  177. Tormos A, Rius Pérez S, Jorques M, Rada P, Ramírez L, Valverde A, et al. p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging. PLoS ONE. 2017;12:e0171738 pubmed publisher
  178. Zhu Y, Kawaguchi K, Kiyama R. Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors. PLoS ONE. 2017;12:e0171390 pubmed publisher
  179. Xiang J, Yang S, Xin N, Gaertig M, Reeves R, Li S, et al. DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome. Proc Natl Acad Sci U S A. 2017;114:E1224-E1233 pubmed publisher
  180. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  181. Ha S, Jin F, Kwak C, Abekura F, Park J, Park N, et al. Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells. Peerj. 2017;5:e2895 pubmed publisher
  182. Cai L, Wang H, Yang Q. CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma. Oncol Lett. 2017;13:51-56 pubmed publisher
  183. Marquez Vilendrer S, Rai S, Gramling S, Lu L, Reisman D. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo. Oncoscience. 2016;3:337-350 pubmed publisher
  184. Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed publisher
  185. Jafari N, Kim H, Park R, Li L, Jang M, Morris A, et al. CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells. PLoS ONE. 2017;12:e0170327 pubmed publisher
  186. Cao H, Yu S, Chen D, Jing C, Wang Z, Ma R, et al. Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment. FEBS Open Bio. 2017;7:35-43 pubmed publisher
  187. Major J, Dewan A, Salih M, Leddy J, Tuana B. E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy. PLoS ONE. 2017;12:e0170066 pubmed publisher
  188. Zhu J, Wang P, Yu Z, Lai W, Cao Y, Huang P, et al. Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells. Am J Transl Res. 2016;8:5569-5579 pubmed
  189. Hussain R, Macklin W. Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell Cycle. J Neurosci. 2017;37:397-412 pubmed publisher
  190. Li C, Chang L, Chen Z, Liu Z, Wang Y, Ye Q. The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration. Int J Mol Med. 2017;39:347-356 pubmed publisher
  191. Li S, Sun Z, Zhang Y, Ruan Y, Chen Q, Gong W, et al. COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation. Oncotarget. 2017;8:10185-10198 pubmed publisher
  192. Chaney S, Mukherjee S, Giddabasappa A, Rueda E, Hamilton W, Johnson J, et al. Increased proliferation of late-born retinal progenitor cells by gestational lead exposure delays rod and bipolar cell differentiation. Mol Vis. 2016;22:1468-1489 pubmed
  193. Sun J, Liu X, Gao H, Zhang L, Ji Q, Wang Z, et al. Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis. Oncotarget. 2017;8:11489-11506 pubmed publisher
  194. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  195. Lazaro S, Perez Crespo M, Enguita A, Hernandez P, Martínez Palacio J, Oteo M, et al. Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation. Oncotarget. 2017;8:4373-4386 pubmed publisher
  196. Liu L, Guan H, Li Y, Ying Z, Wu J, Zhu X, et al. Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness. Mol Cell Biol. 2017;37: pubmed publisher
  197. Nuzzo A, Giuffrida D, Masturzo B, Mele P, Piccoli E, Eva C, et al. Altered expression of G1/S phase cell cycle regulators in placental mesenchymal stromal cells derived from preeclamptic pregnancies with fetal-placental compromise. Cell Cycle. 2017;16:200-212 pubmed publisher
  198. Walline H, Carey T, Goudsmit C, Bellile E, D Souza G, Peterson L, et al. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res. 2017;15:179-188 pubmed publisher
  199. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed publisher
  200. Hong Y, Liang H, Uzair Ur Rehman -, Wang Y, Zhang W, Zhou Y, et al. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer. Sci Rep. 2016;6:37421 pubmed publisher
  201. Song H, Li L, Zhong L, Yang R, Jiang K, Yang X, et al. NLS?RAR? modulates acute promyelocytic leukemia NB4 cell proliferation and differentiation via the PI3K/AKT pathway. Mol Med Rep. 2016;14:5495-5500 pubmed publisher
  202. Cao L, Riascos Bernal D, Chinnasamy P, Dunaway C, Hou R, Pujato M, et al. Control of mitochondrial function and cell growth by the atypical cadherin Fat1. Nature. 2016;539:575-578 pubmed publisher
  203. Fujimura K, Mitsuhashi T, Shibata S, Shimozato S, Takahashi T. In Utero Exposure to Valproic Acid Induces Neocortical Dysgenesis via Dysregulation of Neural Progenitor Cell Proliferation/Differentiation. J Neurosci. 2016;36:10908-10919 pubmed
  204. Harrod A, Fulton J, Nguyen V, Periyasamy M, Ramos Garcia L, Lai C, et al. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene. 2017;36:2286-2296 pubmed publisher
  205. Zhao Y, Fan D, Ru B, Cheng K, Hu S, Zhang J, et al. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells. Eur J Cancer. 2016;68:38-50 pubmed publisher
  206. Lu W, Shi J, Zhang J, Lv Z, Guo F, Huang H, et al. CXCL12/CXCR4 Axis Regulates Aggrecanase Activation and Cartilage Degradation in a Post-Traumatic Osteoarthritis Rat Model. Int J Mol Sci. 2016;17: pubmed
  207. Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed publisher
  208. Soon G, Ow G, Chan H, Ng S, Wang S. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases. Ann Diagn Pathol. 2016;24:40-6 pubmed publisher
  209. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  210. Yao J, Qin L, Miao S, Wang X, Wu X. Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1. Oncol Lett. 2016;12:1840-1848 pubmed
  211. Li J, Yang Z, Chen Z, Bao Y, Zhang H, Fang X, et al. ATF3 suppresses ESCC via downregulation of ID1. Oncol Lett. 2016;12:1642-1648 pubmed
  212. Kang M, Jeong K, Kim W, Lee H, Gong G, Suh N, et al. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer. Oncogene. 2017;36:1745-1752 pubmed publisher
  213. Wu Y, Xie R, Liu X, Wang J, Peng Y, Tang W, et al. Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer. Oncol Rep. 2016;36:2151-9 pubmed publisher
  214. Zak M, van Oort T, Hendriksen F, Garcia M, Vassart G, Grolman W. LGR4 and LGR5 Regulate Hair Cell Differentiation in the Sensory Epithelium of the Developing Mouse Cochlea. Front Cell Neurosci. 2016;10:186 pubmed publisher
  215. Doobin D, Kemal S, Dantas T, Vallee R. Severe NDE1-mediated microcephaly results from neural progenitor cell cycle arrests at multiple specific stages. Nat Commun. 2016;7:12551 pubmed publisher
  216. Gao S, Yang X, Wang M. Inhibitory effects of B?cell translocation gene 2 on skin cancer cells via the Wnt/??catenin signaling pathway. Mol Med Rep. 2016;14:3464-8 pubmed publisher
  217. Shi Y, He Z, Jia Z, Xu C. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo. Mol Med Rep. 2016;14:2921-8 pubmed publisher
  218. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy. J Thorac Oncol. 2016;11:2193-2201 pubmed publisher
  219. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  220. Fiedor E, Gregoraszczuk E. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines. Cancer Chemother Pharmacol. 2016;78:611-22 pubmed publisher
  221. Song J, Song L, Herrera A, Venkataraman G, Murata Collins J, Bedell V, et al. Cyclin D1 expression in peripheral T-cell lymphomas. Mod Pathol. 2016;29:1306-1312 pubmed publisher
  222. Kurita D, Takeuchi K, Kobayashi S, Hojo A, Uchino Y, Sakagami M, et al. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior. Virchows Arch. 2016;469:471-6 pubmed publisher
  223. Fan C, Jia L, Zheng Y, Jin C, Liu Y, Liu H, et al. MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2/NOTCH1/CYCLIN D1 Coregulatory Network. Stem Cell Reports. 2016;7:236-48 pubmed publisher
  224. Xia X, Yu Y, Zhang L, Ma Y, Wang H. Inhibitor of DNA binding 1 regulates cell cycle progression of endothelial progenitor cells through induction of Wnt2 expression. Mol Med Rep. 2016;14:2016-24 pubmed publisher
  225. Ocón B, Aranda C, Gámez Belmonte R, Suárez M, Zarzuelo A, Martinez Augustin O, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73-88 pubmed publisher
  226. Urbán N, van den Berg D, Forget A, Andersen J, Demmers J, Hunt C, et al. Return to quiescence of mouse neural stem cells by degradation of a proactivation protein. Science. 2016;353:292-5 pubmed publisher
  227. Gvozdenović A, Boro A, Meier D, Bode Lesniewska B, Born W, Muff R, et al. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model. Oncotarget. 2016;7:55141-55154 pubmed publisher
  228. Troxell M, Higgins J. Renal cell carcinoma in kidney allografts: histologic types, including biphasic papillary carcinoma. Hum Pathol. 2016;57:28-36 pubmed publisher
  229. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  230. Wu D, Chen C, Wu Z, Liu B, Gao L, Yang Q, et al. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma. J Exp Clin Cancer Res. 2016;35:108 pubmed publisher
  231. Han A, Li J, Li Y, Wang Y, Bergholz J, Zhang Y, et al. p63α modulates c-Myc activity via direct interaction and regulation of MM1 protein stability. Oncotarget. 2016;7:44277-44287 pubmed publisher
  232. Tsai K, Leung C, Lo Y, Chen T, Chan W, Yu S, et al. Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer. Sci Rep. 2016;6:28176 pubmed publisher
  233. Li J, Bao Q, Chen S, Liu H, Feng J, Qin H, et al. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/?-catenin signaling in mice. J Orthop Res. 2017;35:812-819 pubmed publisher
  234. Zhao X, Wang J, Xiao L, Xu Q, Zhao E, Zheng X, et al. Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms. Mol Med Rep. 2016;14:1067-74 pubmed publisher
  235. Park J, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, et al. Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids. PLoS ONE. 2016;11:e0156334 pubmed publisher
  236. Zheng J, Huang X, Tan W, Yu D, Du Z, Chang J, et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat Genet. 2016;48:747-57 pubmed publisher
  237. Chen P, Qin L, Li G, Tellides G, Simons M. Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression. EMBO Mol Med. 2016;8:712-28 pubmed publisher
  238. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  239. Fusté N, Fernández Hernández R, Cemeli T, Mirantes C, Pedraza N, Rafel M, et al. Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin. Nat Commun. 2016;7:11581 pubmed publisher
  240. Morris J, Moseley V, Cabang A, Coleman K, Wei W, Garrett Mayer E, et al. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXR? expression in human colon cancer cells. Oncotarget. 2016;7:35313-26 pubmed publisher
  241. Lombardo G, Dentelli P, Togliatto G, Rosso A, Gili M, Gallo S, et al. Activated Stat5 trafficking Via Endothelial Cell-derived Extracellular Vesicles Controls IL-3 Pro-angiogenic Paracrine Action. Sci Rep. 2016;6:25689 pubmed publisher
  242. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  243. O Santos A, Parrini M, Camonis J. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases. PLoS ONE. 2016;11:e0154840 pubmed publisher
  244. Welk V, Coux O, Kleene V, Abeza C, Trumbach D, Eickelberg O, et al. Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes. J Biol Chem. 2016;291:13147-59 pubmed publisher
  245. Chatterjee I, Baruah J, Lurie E, Wary K. Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development. Cardiovasc Res. 2016;111:105-18 pubmed publisher
  246. Chaudhary S, Madhukrishna B, Adhya A, Keshari S, Mishra S. Overexpression of caspase 7 is ER? dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219 pubmed publisher
  247. Xiao L, Shi X, Zhang Y, Zhu Y, Zhu L, Tian W, et al. YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells. Onco Targets Ther. 2016;9:1105-14 pubmed publisher
  248. Shi J, CUI N, Wang S, Zhao M, Wang B, Wang Y, et al. Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model. FEBS Open Bio. 2016;6:33-42 pubmed publisher
  249. Yan B, Zhang Z, Jin D, Cai C, Jia C, Liu W, et al. mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation. Nat Commun. 2016;7:11151 pubmed publisher
  250. Li J, Tang C, Li L, Li R, Fan Y. Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo. J Exp Clin Cancer Res. 2016;35:61 pubmed publisher
  251. Tomei P, Masola V, Granata S, Bellin G, Carratu P, Ficial M, et al. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation. J Nephrol. 2016;29:881-891 pubmed
  252. Abrosimov A, Dvinskikh N, Sidorin A. Cells of Benign and Borderline Thyroid Tumor Express Malignancy Markers. Bull Exp Biol Med. 2016;160:698-701 pubmed publisher
  253. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed publisher
  254. Antony A, Paillard M, Moffat C, Juskeviciute E, Correnti J, Bolon B, et al. MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration. Nat Commun. 2016;7:10955 pubmed publisher
  255. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  256. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  257. Xu T, Zong Y, Peng L, Kong S, Zhou M, Zou J, et al. Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis. Onco Targets Ther. 2016;9:815-22 pubmed publisher
  258. Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed publisher
  259. Nair H, Baker R, Owston M, Escalona R, Dick E, Vandeberg J, et al. An efficient model of human endometriosis by induced unopposed estrogenicity in baboons. Oncotarget. 2016;7:10857-69 pubmed publisher
  260. Hong J, Lee J, Chung I. Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1. J Cell Sci. 2016;129:1566-79 pubmed publisher
  261. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed publisher
  262. Lanza D, Dawson E, Rao P, Heaney J. Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation. Cell Cycle. 2016;15:919-30 pubmed publisher
  263. Kan H, Huang Y, Li X, Liu D, Chen J, Shu M. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Oncotarget. 2016;7:14336-49 pubmed publisher
  264. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed publisher
  265. Taverna E, Mora Bermúdez F, Strzyz P, Florio M, Icha J, Haffner C, et al. Non-canonical features of the Golgi apparatus in bipolar epithelial neural stem cells. Sci Rep. 2016;6:21206 pubmed publisher
  266. Hong M, Nam K, Kim K, Kim S, Kim I. The small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives regulate global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha. Cell Stress Chaperones. 2016;21:485-97 pubmed publisher
  267. Wu T, Li Y, Liu B, Zhang S, Wu L, Zhu X, et al. Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway. PLoS ONE. 2016;11:e0149361 pubmed publisher
  268. Lamba Saini M, Bouzin C, Weynand B, Marbaix E. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis. PLoS ONE. 2016;11:e0148656 pubmed publisher
  269. Ge S, Zhang J, Du Y, Hu B, Zhou Z, Lou J. Dynamic changes in the gene expression profile during rat oral carcinogenesis induced by 4-nitroquinoline 1-oxide. Mol Med Rep. 2016;13:2561-9 pubmed publisher
  270. Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. J Cell Mol Med. 2016;20:842-54 pubmed publisher
  271. Xu C, Ochi H, Fukuda T, Sato S, Sunamura S, Takarada T, et al. Circadian Clock Regulates Bone Resorption in Mice. J Bone Miner Res. 2016;31:1344-55 pubmed publisher
  272. Podmirseg S, Jäkel H, Ranches G, Kullmann M, Sohm B, Villunger A, et al. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 2016;35:4580-90 pubmed publisher
  273. Kourtidis A, Anastasiadis P. PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications. Cell Cycle. 2016;15:498-505 pubmed publisher
  274. Panda A, Abdelmohsen K, Martindale J, Di Germanio C, Yang X, Grammatikakis I, et al. Novel RNA-binding activity of MYF5 enhances Ccnd1/Cyclin D1 mRNA translation during myogenesis. Nucleic Acids Res. 2016;44:2393-408 pubmed publisher
  275. Kanter M, Turan G, Usta C, Usta A, Esen H, Tavlı L, et al. Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms. J Mol Histol. 2016;47:145-52 pubmed publisher
  276. Zhang J, Weng Z, Tsang K, Tsang L, Chan H, Jiang X. MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells. PLoS ONE. 2016;11:e0148062 pubmed publisher
  277. Jiang C, Fang X, Jiang Y, Shen F, Hu Z, Li X, et al. TNF-α induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model. Int J Biochem Cell Biol. 2016;72:118-124 pubmed publisher
  278. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  279. Carabalona A, Hu D, Vallee R. KIF1A inhibition immortalizes brain stem cells but blocks BDNF-mediated neuronal migration. Nat Neurosci. 2016;19:253-62 pubmed publisher
  280. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  281. Lv H, Zhang Z, Wu X, Wang Y, Li C, Gong W, et al. Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent. PLoS ONE. 2016;11:e0145195 pubmed publisher
  282. Chen X, Dong X, Gao H, Jiang Y, Jin Y, Chang Y, et al. Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep. 2016;13:689-96 pubmed publisher
  283. Mayr C, Wagner A, Loeffelberger M, Brückner D, Jakab M, Berr F, et al. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells. Oncotarget. 2016;7:745-58 pubmed publisher
  284. Zemke M, Draganova K, Klug A, Schöler A, Zurkirchen L, Gay M, et al. Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulation. BMC Biol. 2015;13:103 pubmed publisher
  285. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  286. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  287. Yu D, Makkar G, Dong T, Strickland D, Sarkar R, Monahan T. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism. PLoS ONE. 2015;10:e0141397 pubmed publisher
  288. Wu S, Guo Z, Hopkins C, Wei N, Chu E, Wipf P, et al. Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells. Oncotarget. 2015;6:40866-79 pubmed publisher
  289. Zampieri A, Champagne J, Auzemery B, Fuentes I, Maurel B, Bienvenu F. Hyper sensitive protein detection by Tandem-HTRF reveals Cyclin D1 dynamics in adult mouse. Sci Rep. 2015;5:15739 pubmed publisher
  290. Park Y, Kim S, Kwon T, Kim J, Song I, Shin H, et al. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Oncogene. 2016;35:3503-13 pubmed publisher
  291. Tang J, Chen Y, Cui R, Li D, Xiao L, Lin P, et al. Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition. Mol Med Rep. 2015;12:7907-14 pubmed publisher
  292. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed publisher
  293. Fujino K, Motooka Y, Hassan W, Ali Abdalla M, Sato Y, Kudoh S, et al. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer. Am J Pathol. 2015;185:3164-77 pubmed publisher
  294. Kim S, Bozeman R, Kaisani A, Kim W, Zhang L, Richardson J, et al. Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses. Oncogene. 2016;35:3365-75 pubmed publisher
  295. Lin K, Kao S, Lai C, Chen C, Wu C, Hsu H, et al. Tumor Suppressor Lzap Suppresses Wnt/β-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3. J Biol Chem. 2015;290:29808-19 pubmed publisher
  296. Yao M, Xie C, Kiang M, Teng Y, Harman D, Tiffen J, et al. Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells. Oncotarget. 2015;6:34458-74 pubmed publisher
  297. Chaudhary S, Tang X, Arumugam A, Li C, Srivastava R, Weng Z, et al. Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome. Oncotarget. 2015;6:36789-814 pubmed publisher
  298. Wu L, Guo L, Liang Y, Liu X, Jiang L, Wang L. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway. Oncol Rep. 2015;34:3311-7 pubmed publisher
  299. Xu Y, Zheng Y, Sun X, Yu X, Gu J, Wu W, et al. Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study. Oncotarget. 2015;6:38429-39 pubmed publisher
  300. Kim Y, Chen C, Bolton E. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells. PLoS ONE. 2015;10:e0138286 pubmed publisher
  301. Shain A, Garrido M, Botton T, Talevich E, Yeh I, Sanborn J, et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015;47:1194-9 pubmed publisher
  302. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  303. Quijada P, Hariharan N, Cubillo J, Bala K, Emathinger J, Wang B, et al. Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment. J Biol Chem. 2015;290:25411-26 pubmed publisher
  304. Lee S, Litan A, Li Z, Graves B, Lindsey S, Barwe S, et al. Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity. Mol Cancer. 2015;14:159 pubmed publisher
  305. Zhang G, Xiong K, Ma W, Xu W, Zeng H. Initiate Tumors with Single Cell Spheres Formed in Serum-Containing Medium. J Cancer. 2015;6:901-12 pubmed publisher
  306. Sakabe I, Hu R, Jin L, Clarke R, Kasid U. TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling. Breast Cancer Res Treat. 2015;153:285-97 pubmed publisher
  307. Wong F, Fei J, Mora Bermúdez F, Taverna E, Haffner C, Fu J, et al. Sustained Pax6 Expression Generates Primate-like Basal Radial Glia in Developing Mouse Neocortex. PLoS Biol. 2015;13:e1002217 pubmed publisher
  308. Zhuo W, Ge W, Meng G, Jia S, Zhou X, Liu J. MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression. Mol Med Rep. 2015;12:4989-94 pubmed publisher
  309. Wu M, Lee W, Hua K, Kuo M, Lin M. Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway. PLoS ONE. 2015;10:e0134122 pubmed publisher
  310. Yan K, Li L, Wang X, Hong R, Zhang Y, Yang H, et al. The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells. J Cell Biol. 2015;210:209-24 pubmed publisher
  311. Sarojini S, Pecora A, Milinovikj N, Barbiere J, Gupta S, Hussain Z, et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res. 2015;25:376-89 pubmed publisher
  312. Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein A, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613-23 pubmed
  313. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  314. Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6:14796-813 pubmed
  315. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed publisher
  316. Orlando S, Gallastegui E, Besson A, Abril G, Aligué R, Pujol M, et al. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes. Nucleic Acids Res. 2015;43:6860-73 pubmed publisher
  317. Cantarero L, Sanz García M, Vinograd Byk H, Renbaum P, Levy Lahad E, Lazo P. VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle. Sci Rep. 2015;5:10543 pubmed publisher
  318. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  319. Han Y, Lee J, Lee S. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep. 2015;12:3446-3452 pubmed publisher
  320. Yin C, Tang G, Lu G, Feng X, Keating M, Medeiros L, et al. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. Mod Pathol. 2015;28:1130-7 pubmed publisher
  321. Brunner S, Weber F, Werner J, Agha A, Farkas S, Schlitt H, et al. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg. 2015;15:49 pubmed publisher
  322. Pozo K, Hillmann A, Augustyn A, Plattner F, Hai T, Singh T, et al. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis. Oncotarget. 2015;6:12080-93 pubmed
  323. Wilson C, Jurk D, Fullard N, Banks P, Page A, Luli S, et al. NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat Commun. 2015;6:6818 pubmed publisher
  324. Beca F, Pereira M, Cameselle Teijeiro J, Martins D, Schmitt F. Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer. BMC Cancer. 2015;15:285 pubmed publisher
  325. Fu Q, Chen Z, Gong X, Cai Y, Chen Y, Ma X, et al. β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells. Biochem Biophys Res Commun. 2015;461:21-7 pubmed publisher
  326. Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, et al. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis. Oncotarget. 2015;6:9420-33 pubmed
  327. Li L, Xu Z, Liu G, Xu C, Wang Z, Li X, et al. Expression of 1N3R-Tau isoform inhibits cell proliferation by inducing S phase arrest in N2a cells. PLoS ONE. 2015;10:e0119865 pubmed publisher
  328. Puzio Kuter A, Laddha S, Castillo Martin M, Sun Y, Cordon Cardo C, Chan C, et al. Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. Cell Death Differ. 2015;22:1785-91 pubmed publisher
  329. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed publisher
  330. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clin Epigenetics. 2015;7:32 pubmed publisher
  331. Dubon M, Park K. Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem cell-like cell lines. Exp Ther Med. 2015;9:1185-1191 pubmed
  332. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  333. Wang G, Liu G, Ye Y, Fu Y, Zhang X. The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochem Biophys Res Commun. 2015;459:629-35 pubmed publisher
  334. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, et al. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol. 2015;28:787-98 pubmed publisher
  335. Sun X, Tang S, Xu C, Wang C, Qin S, Du N, et al. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1. J Cell Mol Med. 2015;19:1357-65 pubmed publisher
  336. Fujimura N, Klimova L, Antosova B, Smolikova J, Machon O, Kozmik Z. Genetic interaction between Pax6 and β-catenin in the developing retinal pigment epithelium. Dev Genes Evol. 2015;225:121-8 pubmed publisher
  337. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed publisher
  338. Gergics P, Brinkmeier M, Camper S. Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia. Mol Endocrinol. 2015;29:597-612 pubmed publisher
  339. Hsieh W, Huang Y, Wang T, Ming Y, Tsai C, Pang J. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48:187-97 pubmed publisher
  340. Kondapalli K, Llongueras J, Capilla González V, Prasad H, Hack A, Smith C, et al. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma. Nat Commun. 2015;6:6289 pubmed publisher
  341. Barrichon M, Hadi T, Wendremaire M, Ptasinski C, Seigneuric R, Marcion G, et al. Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells. Br J Pharmacol. 2015;172:2974-90 pubmed publisher
  342. Mishra R, Nagini S, Rana A. Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression. Mol Cancer. 2015;14:20 pubmed publisher
  343. Bai M, Yuan M, Liao H, Chen J, Xie B, Yan D, et al. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma. Oncol Rep. 2015;33:1745-52 pubmed publisher
  344. Niu Z, Liu H, Zhou M, Wang H, Liu Y, Li X, et al. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2015;47:183-91 pubmed publisher
  345. Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim J, et al. The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells. Cell Cycle. 2015;14:990-1000 pubmed publisher
  346. Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94 pubmed
  347. Chong K, Hsu C, Hung T, Hu H, Huang T, Wang T, et al. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther. 2015;16:149-59 pubmed publisher
  348. Huang S, Zou X, Zhu J, Fu Y, Lin Q, Liang Y, et al. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy. J Cell Mol Med. 2015;19:608-19 pubmed publisher
  349. Blanchard Z, Paul B, Craft B, ElShamy W. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Breast Cancer Res. 2015;17:5 pubmed publisher
  350. Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, et al. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog. 2015;54:1710-21 pubmed publisher
  351. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed publisher
  352. Zhao H, Xie C, Lin X, Zhao Y, Han Y, Fan C, et al. Coexpression of IQ-domain GTPase-activating protein 1 (IQGAP1) and Dishevelled (Dvl) is correlated with poor prognosis in non-small cell lung cancer. PLoS ONE. 2014;9:e113713 pubmed publisher
  353. Yuan G, Yang G, Zheng Y, Zhu X, Chen Z, Zhang Z, et al. The non-canonical BMP and Wnt/β-catenin signaling pathways orchestrate early tooth development. Development. 2015;142:128-39 pubmed publisher
  354. Dabydeen S, Kang K, Díaz Cruz E, Alamri A, Axelrod M, Bouker K, et al. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. Carcinogenesis. 2015;36:122-32 pubmed publisher
  355. Wang T, Chen Z, Zhu Y, Pan Q, Liu Y, Qi X, et al. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells. J Biol Chem. 2015;290:448-56 pubmed publisher
  356. Hung T, Hsu S, Cheng C, Choo K, Tseng C, Chen T, et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014;5:12273-90 pubmed
  357. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, et al. PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathog. 2014;10:e1004514 pubmed publisher
  358. Liu X, Yang W, Zheng P. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas. Oncotarget. 2014;5:10870-85 pubmed
  359. Zhang N, Chu E, Zhang J, Li X, Liang Q, Chen J, et al. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway. Oncotarget. 2014;5:8330-40 pubmed
  360. Zhang Q, Chabot Richards D, Evans M, Spengel K, Andrews J, Kang H, et al. A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms. Int J Lab Hematol. 2015;37:390-402 pubmed publisher
  361. Brun C, Périé L, Baraige F, Vernus B, Bonnieu A, Blanquet V. Absence of hyperplasia in Gasp-1 overexpressing mice is dependent on myostatin up-regulation. Cell Physiol Biochem. 2014;34:1241-59 pubmed publisher
  362. Joliot V, Ait Mohamed O, Battisti V, Pontis J, Philipot O, Robin P, et al. The SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation. PLoS ONE. 2014;9:e108858 pubmed publisher
  363. Fan C, Jiang G, Zhang X, Miao Y, Lin X, Luan L, et al. Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1. Mol Carcinog. 2015;54 Suppl 1:E138-47 pubmed publisher
  364. Contreras Jurado C, García Serrano L, Martínez Fernández M, Ruiz Llorente L, Paramio J, Aranda A. Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. PLoS ONE. 2014;9:e108137 pubmed publisher
  365. Dumitrescu A, Aberdeen G, Pepe G, Albrecht E. Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex. Endocrinology. 2014;155:4774-84 pubmed publisher
  366. Perry M, Dufour C, Eichner L, Tsang D, Deblois G, Muller W, et al. ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction. Mol Cell Biol. 2014;34:4232-43 pubmed publisher
  367. Tian L, Wang C, Hagen F, Gormley M, Addya S, Soccio R, et al. Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cells. Oncotarget. 2014;5:7303-15 pubmed
  368. Valkenburg K, Yu X, De Marzo A, Spiering T, Matusik R, Williams B. Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. Prostate. 2014;74:1506-20 pubmed publisher
  369. Oliveira C, de Bock C, Molloy T, Sadeqzadeh E, Geng X, Hersey P, et al. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer. 2014;14:630 pubmed publisher
  370. Yi T, Kabha E, Papadopoulos E, Wagner G. 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis. Oncotarget. 2014;5:6028-37 pubmed
  371. Inada A, Inada O, Fujii N, Fujishima K, Inai T, Fujii H, et al. ?-cell induction in vivo in severely diabetic male mice by changing the circulating levels and pattern of the ratios of estradiol to androgens. Endocrinology. 2014;155:3829-42 pubmed publisher
  372. Resch U, Cuapio A, Sturtzel C, Hofer E, de Martin R, Holper Schichl Y. Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis. J Biol Chem. 2014;289:25088-100 pubmed publisher
  373. Gao Y, Chen Y, Xu D, Wang J, Yu G. Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer. 2014;14:520 pubmed publisher
  374. Bañón Maneus E, Rovira J, Ramírez Bajo M, Moya Rull D, Hierro Garcia N, Takenaka S, et al. Wnt pathway activation in long term remnant rat model. Biomed Res Int. 2014;2014:324713 pubmed publisher
  375. Costales M, Lopez F, García Inclán C, Fernandez S, Marcos C, Llorente J, et al. Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model. Head Neck. 2015;37:1769-75 pubmed publisher
  376. Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302-15 pubmed publisher
  377. Ormanns S, Neumann J, Horst D, Kirchner T, Jung A. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear ?-Catenin depend on active PI3K signaling. Oncotarget. 2014;5:2999-3011 pubmed
  378. Yu W, Bonnet M, Farso M, Ma K, Chabot J, Martin E, et al. The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease. BMC Neurosci. 2014;15:73 pubmed publisher
  379. Chien P, Hsieh H, Chi P, Yang C. PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes. Br J Pharmacol. 2014;171:4504-19 pubmed publisher
  380. Alanis D, Chang D, Akiyama H, Krasnow M, Chen J. Two nested developmental waves demarcate a compartment boundary in the mouse lung. Nat Commun. 2014;5:3923 pubmed publisher
  381. Velicky P, Haider S, Otti G, Fiala C, Pollheimer J, Knöfler M. Notch-dependent RBPJ? inhibits proliferation of human cytotrophoblasts and their differentiation into extravillous trophoblasts. Mol Hum Reprod. 2014;20:756-66 pubmed publisher
  382. Moriarity B, Rahrmann E, Beckmann D, Conboy C, Watson A, Carlson D, et al. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS ONE. 2014;9:e96114 pubmed publisher
  383. Kiszner G, Wichmann B, Nemeth I, Varga E, Meggyeshazi N, Teleki I, et al. Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas. Virchows Arch. 2014;464:603-12 pubmed publisher
  384. Hashimoto Y, Shirane M, Matsuzaki F, Saita S, Ohnishi T, Nakayama K. Protrudin regulates endoplasmic reticulum morphology and function associated with the pathogenesis of hereditary spastic paraplegia. J Biol Chem. 2014;289:12946-61 pubmed publisher
  385. Scharfmann R, Pechberty S, Hazhouz Y, von Bülow M, Bricout Neveu E, Grenier Godard M, et al. Development of a conditionally immortalized human pancreatic ? cell line. J Clin Invest. 2014;124:2087-98 pubmed publisher
  386. Li J, Bai X, Zou Y, Hao Y, Xu X. Aberration of the Wnt signaling pathway in pulmonary fatal adenocarcinoma: a case report. Chin J Cancer Res. 2014;26:E13-6 pubmed publisher
  387. Nobs L, Baranek C, Nestel S, Kulik A, Kapfhammer J, Nitsch C, et al. Stage-specific requirement for cyclin D1 in glial progenitor cells of the cerebral cortex. Glia. 2014;62:829-39 pubmed publisher
  388. Neumeister V, Parisi F, England A, Siddiqui S, Anagnostou V, Zarrella E, et al. A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue. Lab Invest. 2014;94:467-74 pubmed publisher
  389. Berkenkamp B, Susnik N, Baisantry A, Kuznetsova I, Jacobi C, Sörensen Zender I, et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE. 2014;9:e88071 pubmed publisher
  390. Marttinen M, Pajari A, Paivarinta E, Storvik M, Marttinen P, Nurmi T, et al. Plant sterol feeding induces tumor formation and alters sterol metabolism in the intestine of Apc(Min) mice. Nutr Cancer. 2014;66:259-69 pubmed publisher
  391. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2014;74:829-39 pubmed publisher
  392. Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, et al. LRH1 as a driving factor in pancreatic cancer growth. Cancer Lett. 2014;345:85-90 pubmed publisher
  393. Bhaskar K, Maphis N, Xu G, Varvel N, Kokiko Cochran O, Weick J, et al. Microglial derived tumor necrosis factor-? drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol Dis. 2014;62:273-85 pubmed publisher
  394. Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng L, et al. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-?B. J Hepatol. 2014;60:306-12 pubmed publisher
  395. Sreevalsan S, Safe S. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. Mol Cancer Ther. 2013;12:2483-93 pubmed publisher
  396. Mudaliar M, Haggart R, Miele G, Sellar G, Tan K, Goodlad J, et al. Comparative gene expression profiling identifies common molecular signatures of NF-?B activation in canine and human diffuse large B cell lymphoma (DLBCL). PLoS ONE. 2013;8:e72591 pubmed publisher
  397. Kucherlapati M, Esfahani S, Habibollahi P, Wang J, Still E, Bronson R, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PLoS ONE. 2013;8:e68817 pubmed publisher
  398. Fausti F, Di Agostino S, Cioce M, Bielli P, Sette C, Pandolfi P, et al. ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence. Cell Death Differ. 2013;20:1498-509 pubmed publisher
  399. Shan L, Li X, Liu L, Ding X, Wang Q, Zheng Y, et al. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation. Oncogene. 2014;33:3205-16 pubmed publisher
  400. Nobs L, Nestel S, Kulik A, Nitsch C, Atanasoski S. Cyclin D1 is required for proliferation of Olig2-expressing progenitor cells in the injured cerebral cortex. Glia. 2013;61:1443-55 pubmed publisher
  401. Bradford C, Kumar B, Bellile E, Lee J, Taylor J, D SILVA N, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014;124:179-87 pubmed publisher
  402. Comstock C, Augello M, Goodwin J, de Leeuw R, Schiewer M, Ostrander W, et al. Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 2013;32:5481-91 pubmed publisher
  403. Mitterberger M, Zwerschke W. Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. J Gerontol A Biol Sci Med Sci. 2013;68:1356-76 pubmed publisher
  404. Wang J, El Masry N, Talbot I, Tomlinson I, Alison M, El Bahrawy M. Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients. Gastroenterol Res Pract. 2013;2013:107534 pubmed publisher
  405. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed publisher
  406. Jullien L, Mestre M, Roux P, Gire V. Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Res. 2013;41:900-11 pubmed publisher
  407. Alimova I, Birks D, Harris P, Knipstein J, Venkataraman S, Marquez V, et al. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. Neuro Oncol. 2013;15:149-60 pubmed publisher
  408. Lara P, Lloret M, Valenciano A, Clavo B, Pinar B, Rey A, et al. Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors. Strahlenther Onkol. 2012;188:1139-45 pubmed publisher
  409. Cigna N, Farrokhi Moshai E, Brayer S, Marchal Sommé J, Wemeau Stervinou L, Fabre A, et al. The hedgehog system machinery controls transforming growth factor-?-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. Am J Pathol. 2012;181:2126-37 pubmed publisher
  410. Chen S, Fu S, Hsu S, Huang Y, Hsu B. Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication. Int J Endocrinol. 2012;2012:417390 pubmed publisher
  411. Akli S, Zhang X, Bondaruk J, Tucker S, Czerniak P, Benedict W, et al. Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer. Cell Cycle. 2012;11:1468-76 pubmed publisher
  412. Deckelbaum R, Holmes G, Zhao Z, Tong C, Basilico C, Loomis C. Regulation of cranial morphogenesis and cell fate at the neural crest-mesoderm boundary by engrailed 1. Development. 2012;139:1346-58 pubmed publisher
  413. Zuo Z, Tang Y, Bi C, Zhang W, Zhao S, Wang X, et al. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol. 2011;6:123 pubmed publisher
  414. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  415. Loponen H, Ylikoski J, Albrecht J, Pirvola U. Restrictions in cell cycle progression of adult vestibular supporting cells in response to ectopic cyclin D1 expression. PLoS ONE. 2011;6:e27360 pubmed publisher
  416. Na B, Huang Z, Wang Q, Qi Z, Tian Y, Lu C, et al. Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury. PLoS ONE. 2011;6:e26240 pubmed publisher
  417. Wang G, Yan Q, Woods A, Aubrey L, Feng Q, Beier F. Inducible nitric oxide synthase-nitric oxide signaling mediates the mitogenic activity of Rac1 during endochondral bone growth. J Cell Sci. 2011;124:3405-13 pubmed publisher
  418. Korgun E, Unek G, Herrera E, Jones C, Wadsack C, Kipmen Korgun D, et al. Mapping of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta. Histochem Cell Biol. 2011;136:267-78 pubmed publisher
  419. van der Weyden L, Alcolea M, Jones P, Rust A, Arends M, Adams D. Acute sensitivity of the oral mucosa to oncogenic K-ras. J Pathol. 2011;224:22-32 pubmed publisher
  420. Hsu F, Yang M, Lin E, Tseng C, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011;300:E902-8 pubmed publisher
  421. Cheuk W, Tam F, Chan A, Luk I, Yuen A, Chan W, et al. Idiopathic cervical fibrosis--a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol. 2010;34:1678-85 pubmed publisher
  422. Yang G, Chang B, Yang F, Guo X, Cai K, Xiao X, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010;16:3171-81 pubmed publisher
  423. Leong A, Haffajee Z. Citraconic anhydride: a new antigen retrieval solution. Pathology. 2010;42:77-81 pubmed publisher
  424. Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere Vince D, Dumollard J, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res. 2009;15:5696-703 pubmed publisher
  425. Chimploy K, Díaz G, Li Q, Carter O, Dashwood W, Mathews C, et al. E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin. Int J Cancer. 2009;125:2086-94 pubmed publisher
  426. Rogers S, Box C, Chambers P, Barbachano Y, Nutting C, Rhys Evans P, et al. Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J Pathol. 2009;218:122-30 pubmed publisher
  427. Dawson M, Opat S, Taouk Y, Donovan M, Zammit M, Monaghan K, et al. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma. Clin Cancer Res. 2009;15:714-22 pubmed publisher
  428. Tiedemann R, Schmidt J, Keats J, Shi C, Zhu Y, Palmer S, et al. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood. 2009;113:4027-37 pubmed publisher
  429. Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet Bauchu E, et al. Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival. Leuk Lymphoma. 2008;49:1403-6 pubmed publisher
  430. Rowan S, Conley K, Le T, Donner A, Maas R, Brown N. Notch signaling regulates growth and differentiation in the mammalian lens. Dev Biol. 2008;321:111-22 pubmed publisher
  431. Kajanne R, Leppa S, Luukkainen P, Ustinov J, Thiel A, Ristimaki A, et al. Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine. Pediatr Res. 2007;62:570-5 pubmed
  432. Jones L, Tilli M, Assefnia S, Torre K, Halama E, Parrish A, et al. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene. 2008;27:794-802 pubmed
  433. Mottolese M, Orlandi G, Sperduti I, Merola R, Buglioni S, Di Benedetto A, et al. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile. Am J Surg Pathol. 2007;31:247-54 pubmed
  434. Rao H, Thirumangalakudi L, Desmond P, Grammas P. Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem. 2007;101:498-505 pubmed
  435. Jones A, Jonsson A, Aro H. Neisseria gonorrhoeae infection causes a G1 arrest in human epithelial cells. FASEB J. 2007;21:345-55 pubmed
  436. Reis Filho J, Simpson P, Turner N, Lambros M, Jones C, Mackay A, et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res. 2006;12:6652-62 pubmed
  437. Horn L, Richter C, Einenkel J, Tannapfel A, Liebert U, Leo C. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Ann Diagn Pathol. 2006;10:193-6 pubmed
  438. Akimoto M, Cheng H, Zhu D, Brzezinski J, Khanna R, Filippova E, et al. Targeting of GFP to newborn rods by Nrl promoter and temporal expression profiling of flow-sorted photoreceptors. Proc Natl Acad Sci U S A. 2006;103:3890-5 pubmed
  439. Mikami T, Yoshida T, Shiraishi H, Tokuyama W, Motoori T, Okayasu I. Bottom-up cell proliferation with cyclin A and p27Kip1 expression in ulcerative colitis-associated dysplasia. Pathol Int. 2006;56:10-6 pubmed
  440. Takahashi Y, Fukusato T, Aita K, Toida S, Fukushima J, Imamura T, et al. Solid pseudopapillary tumor of the pancreas with metastases to the lung and liver. Pathol Int. 2005;55:792-6 pubmed
  441. Uziel T, Zindy F, Xie S, Lee Y, Forget A, Magdaleno S, et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 2005;19:2656-67 pubmed
  442. Konoplev S, Medeiros L, Bueso Ramos C, Jorgensen J, Lin P. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Am J Clin Pathol. 2005;124:414-20 pubmed
  443. Misikangas M, Pajari A, Paivarinta E, Mutanen M. Promotion of adenoma growth by dietary inulin is associated with increase in cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa. J Nutr Biochem. 2005;16:402-9 pubmed
  444. Kamoshida S, Matsuoka H, Shiogama K, Matsuyama A, Shimomura R, Inada K, et al. Immunohistochemical analysis of thymidylate synthase, p16(INK4a), cyclin-dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: significance of p16(INK4a)-mediated cellular arrest as an indicator of chemosensitivi. Pathol Int. 2004;54:564-75 pubmed
  445. Pantanowitz L, Dezube B, Pinkus G, Tahan S. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol. 2004;31:26-34 pubmed
  446. Adachi A, Tamaru J, Kaneko K, Kuroda H, Miura I, Kojima T, et al. No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma. Pathol Int. 2004;54:16-25 pubmed
  447. Haegele L, Ingold B, Naumann H, Tabatabai G, Ledermann B, Brandner S. Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol Cell Neurosci. 2003;24:696-708 pubmed
  448. Yamazaki K, Hanami K, Nagao T, Asoh A, Sugano I, Ishida Y. Increased cyclin D1 expression in cancer of the ampulla of Vater: relevance to nuclear beta catenin accumulation and k-ras gene mutation. Mol Pathol. 2003;56:336-41 pubmed
  449. Schlette E, Fu K, Medeiros L. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol. 2003;120:760-6 pubmed
  450. Beasley M, Lantuejoul S, Abbondanzo S, Chu W, Hasleton P, Travis W, et al. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol. 2003;34:136-42 pubmed
  451. Friedrichsen B, Richter H, Hansen J, Rhodes C, Nielsen J, Billestrup N, et al. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol. 2003;17:945-58 pubmed
  452. Peiro G, Diebold J, Löhrs U. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Am J Clin Pathol. 2002;118:922-9 pubmed
  453. Xu Y, McKenna R, Asplund S, Kroft S. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. Am J Clin Pathol. 2002;118:758-64 pubmed
  454. Law B, Chytil A, Dumont N, Hamilton E, Waltner Law M, Aakre M, et al. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol. 2002;22:8184-98 pubmed
  455. Gloghini A, Gaidano G, Larocca L, Pierconti F, Cingolani A, Dal Maso L, et al. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1. Am J Pathol. 2002;161:163-71 pubmed
  456. Montagnoli A, Bosotti R, Villa F, Rialland M, Brotherton D, Mercurio C, et al. Drf1, a novel regulatory subunit for human Cdc7 kinase. EMBO J. 2002;21:3171-81 pubmed
  457. Degan M, Doliana R, Gloghini A, Di Francia R, Aldinucci D, Mazzocut Zecchin L, et al. A novel bcl-1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster. J Pathol. 2002;197:256-63 pubmed
  458. Xu Y, McKenna R, Kroft S. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. Am J Clin Pathol. 2002;117:291-300 pubmed
  459. Schlette E, Lai R, Onciu M, Doherty D, Bueso Ramos C, Medeiros L. Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol. 2001;14:1133-40 pubmed
  460. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 2001;20:6050-9 pubmed
  461. Kroft S, Dawson D, McKenna R. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases. Am J Clin Pathol. 2001;115:385-95 pubmed
  462. Kroft S, Howard M, Picker L, Ansari M, Aquino D, McKenna R. De novo CD5+ diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma. Am J Clin Pathol. 2000;114:523-33 pubmed
  463. Carbone A, Gloghini A, Bontempo D, Monini P, Tirelli U, Volpe R, et al. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1). Am J Pathol. 2000;156:1209-15 pubmed
  464. Pérez de Castro I, Malumbres M, Santos J, Pellicer A, Fernandez Piqueras J. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Carcinogenesis. 1999;20:1675-82 pubmed